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SUMMARY 
Chemical ionization mass spectrometry has been used for the rapid and 
quantitative analysis of amino acids, fatty acid, free and bound choles-
terol and estriol in biological fluids. The analysis depends on the ex-
traction of a particular class of metabolites from the sample with an 
organic solvent followed by direct chemical ionization mass spectrometry 
on the extract without prior chromatographic separation. Quantitation has 
been achieved by the addition of stable isotopically labelled internal 
standards and mass spectral peak height measurement of the labelled and 
unlabelled protonated molecular ions. The method permits the determination 
of metabolites of interest down to a level of 25 ng, whilst still maintain-
ing a signal/noise ratio better than 10:1. The analysis is reproducible 
with a standard deviation of less than 5%. 
The procedure has been applied to the analysis of microsamples of 
blood spotted on filter paper, as well as other biological fluids. For 
the analysis of blood amino acids, an 80% alcoholic extract is used which 
is treated with acetic anhydride-methanol. This converts all the amino 
acid to N-acetyl methyl esters which have unique protonated molecular ion 
peaks with the exception of leucine and isoleucine which can not be dis-
tinguished. The new amino acid analysis has been evaluated against the 
Guthrie microbiological inhibition test and against ion-exchange 
chromatography. 
In a similar fashion but by chloroform-methanol extraction of the 
sample without derivatization, free fatty acid and cholesterol levels have 
been quantitized and the results have been compared with thin-layer 
chromatography, gas chromatography and enz3nniatic methods. The new analysis 
has also been applied to a number of clinical situations such as the 
diagnosis of genetic defects and the testing for heterozygosity. 
Ill 
Finally the procedure has been used to study metabolic defects by 
examining blood samples from patients who had been fed stable isotopically 
labelled amino acids. Preliminary experiments on the analysis of protein 
hydrolysates and of estriol in pregnancy urine, suggest that the method 
could also be applied for these purposes. Some of the results obtained in 
this study have been published in the following papers: 
(1) "A rapid and quantitative gas chromatographic determination of 
glutamine in the presence of glutamic acid", Anal. Letters, 9:605 (1976). 
(2) "Rapid and quantitative blood analysis for free fatty acids by 
chemical ionization mass spectrometry", Anal. Letters, 9:1075 (1976). 
(3) "Rapid and quantitative blood amino acid analysis by chemical 
ionization mass spectrometry", Biomed. Mass Spectrometry, (Feb. 1977). 
INTRODUCTION 
During the past 30 years the value of clinical chemistry to health 
care has been increasingly recognized. However, during the last decade the 
cost of clinical services has also increased enormously, and this has been 
countered effectively by instrumental automation. For example the clinical 
auto-analyzer today can complete 20 or more discrete analyses in a 3 ml 
sample at the rate of 40-80 samples per hour. Unfortunately, the 'auto-
analyzer' concept can not be applied to a number of important clinical 
areas which require the quantitative determination of a group of related 
metabolites such as the amino acids or fatty acids, etc. Clinical analysis 
of amino acids and fatty acids, beyond the simple non-specific chemical 
tests, are rather time consuming, require relatively large samples and are 
consequently expensive. The present procedures generally involve extensive 
sample handling, purification and/or derivatization and time-consuming 
chromatographic separation. This complexity of operation requires skilled 
clinical personnel which adds to the cost of the analysis. 
The following summarizes the more important clinical developments in 
the analysis of amino acids and fatty acids over the past 25 years. During 
this period, ion-exchange chromatography and gas chromatography have been 
extensively developed and have remained the major analytical techniques for 
this purpose to this day. 
The basic concept of the amino acid analyzer was developed by Moore 
and Stein in 1951^1). The original amino acid analyzer employed two ion 
exchange columns to effect the separation of the neutral, acidic and basic 
amino acids. This was followed by the collection of the eluate containing 
the isolated amino acids which were subsequently quantitatively analyzed 
for amino acid content. This basic device was modified so as to determine 
automatically the amino acid content of the eluate as it emerged from the 
ion exchange column(2). in this set up, the emerging column eluate is 
mixed with ninhydrin reagent and the solution enters a mixing coil 
immersed in a boiling water bath in which the reaction with ninhydrin is 
completed. The reaction product of ninhydrin with amino acids is a blue 
compound which absorbs light at 570 nm. The absorbance of the eluate 
emerging from the boiling water bath is constantly monitored and recorded 
by a chart recorder. The imino acids, proline and hydroxyproline, form a 
yellow compound upon reaction with ninhydrin, which necessitates the in-
corporation of a second channel to monitor the eluate at 440 nm in order 
to quantitate these amino acids. 
In 1960, Piez and Morris^^^ developed a simplified scheme for the 
automatic analysis of amino acids. It employed a single ion exchange 
column from which the amino acids were eluted with a continuous gradient 
buffer. The single column methodology was critically examined by Hamilton 
(4) 
in 1963 . The instrument was then used for the quantitative determina-
tion of the free amino acids in 0.1 ml of venous blood plasma of the new-
born child^^\ The single ion exchange column possessed the advantage 
that only one application of the sample was required for a complete 
analysis of protein amino acids. This of course was important if only a 
limited amount of physiological fluid was available. The chief drawback 
of the single column system was the change in baseline which appeared with 
the high ion strength buffers in a stepwise system. This baseline shift 
was due to the presence of ammonium ions which contaminated the early 
buffers. 
These first generation analyzers required at least 24 hours per 
analysis and more than 100 nanomoles of each amino acid was needed for a 
quantitative analysis. Over the last ten years, a great deal of effort 
has been expended to increase the sensitivity and speed of the ion exchange 
technique. Kirsten and Kirsten^^^ assembled a micro-amino acid analyzer 
based on anion exchange resins in capillary c o l u m n s T h i s instrument 
was capable of quantitatively resolving as little as two picomoles of an 
amino acid. A commercial microanalyzer using this principle was later de-
veloped, and this instrument was used for a number of clinical applica-
tions such as the study of inborn errors of amino acid metabolism^^^. 
However, this commercial instrument did not completely resolve all the 
(9) 
amino acid in one step. Gressner later modified this microanalyzer by 
changing the buffer pH, which resulted in the resolution of all common 
amino acids of biological interest. By using four Teflon capillary 
columns, which allowed regeneration of two of the columns during a run, a 
greater number of analysis could be run each day. This microanalyzer had 
a precision of + 3.6% for the neutral and acidic amino acids and +4.3% for 
the basic amino acids. The precision of proline was poor at + 8.4% and 
recovery of amino acids was about 90%. This microanalyzer was capable to 
quantitate a mixture containing 150 picomoles of each amino acid, with an 
analysis time of 12 hours. 
In the past four years, some modifications to the ninhydrin detection 
system of the amino acids have been introduced. This new approach offers 
higher sensitivity, and thus widens the scope of application for amino acid 
analysis. The new reagent, fluorescamine^^^\ forms a fluorescent deriva-
tive with the amino acids and it was first used to determine the phenyl-
alanine level in Unfortunately, fluorescamine has only a 
limited solubility in aqueous buffers and thus it must be dissolved in an 
organic solvent (usually acetone) first, before it can be metered to the 
column eluate. Recently a second fluorimetric detection method using (12) 
phtalaldehyde has been developed for use in the amino acid analyzer 
This reagent is more specific for amino acids than fluorescamine because 
the reagent does not react with proteins or peptides. These two reagents 
are already in use in some commercially available amino acid analyzer 
(13) 
systems . The major disadvantage of both detection methods is the in-
ability to form fluorescent derivatives with the two imino amino acids 
proline and hydroxyproline, and a modification of the detection system is 
required to overcome this difficulty. 
In order to shorten the analysis time, Ertingshausen and Adler^^^^ 
later increased the working pressure of the ion exchange separation pro-
cesses to 700-800 psi on a Technicon Multiple Amino Acid Analyzer TSM, 
and they were able to separate the amino acids in 6 hours with a 2-column 
system. Two years later, Benson^^^^reported a 6-hour, high pressure, 
single column analysis for amino acids. Recently, a high pressure 
commercial system capable of operating at 300 psi pressure has been 
developed by Durrum Instruments (U.S.A.), in which a stainless steel, small 
bore (0.176 x 48 cm) column containing 8 micron resin beads is used. This 
machine will carry out a complete amino acid analysis in about 3-5 hours 
and the sensitivity of the system is sufficiently high to allow for the 
analyses of nanomole levels of amino acids in biological fluids. 
Despite these dramatic improvements in the instrumentation, the 
complexity of the operation and the long analysis time have made ion 
exchange chromatography of doubtful value for routine application in a 
clinical chemistry. 
Other methods for the analysis of amino acids in biological fluids 
such as electrophoresis^^^^; thin-layer^^^'^^^ and gas-liquid 
chromatography (GLC) have also been used clinically for the detection of 
amino acid abnormalities, however, with the exception of GLC, they have 
not been applied successfully to a clinically useful quantitative 
technique. 
In the last two decades, gas-liquid chromatography (GLC)^^^^ has 
attained great prominence in analytical chemistry. The inherent speed and 
sensitivity of the technique has focused attention on its possible use in 
clinical situations. The first application of GLC for amino acid was 
(21) 
reported in 1956 . Since then the analytical applications of this 
technique to amino acid analysis has been advanced through extensive 
studies involving numerous derivatization methods, column technology and 
u . u- .. . (22,23,24,25,26) ^ ^ . .. i chromatographic separation systems . Among the most widely 
adopted derivatives for amino acids analysis are the N-trifluoroacetyl 
(27 28 29) (25) n-butyl esters * ' , the N-acetyl n-propyl and the trimethylsilyl 
(30 31) 
derivatives * . Despite the many attempts, the GLC of amino acids is 
still not entirely satisfactory for clinical work as the derivatization 
processes are time consuming, involve complex chemistry, require multiple 
sample manipulations and most of the derivatives are hydrolytically un-
stable. In addition all steps require careful attention to detail, for 
example, some derivatives are very volatile and are readily lost during 
concentration of the sample whilst other derivatives are not sufficiently 
volatile for chromatography on polar columns. The best solution, namely, 
the GLC separation of N-trifluoroacetyl n-butyl esters takes about one hour 
using a two column methodology and 50 nanograms of each amino acid are 
needed, as two derivatization steps—esterification and acetylation—are 
required. 
Prior to derivatization, time consuming clean-up procedures involv-
ing many steps are also required in the specific case of analyzing bio-
logical fluid. The serum and urinary amino acids, for example, are usually 
isolated by ion-exchange chromatographic methods and are retained on the 
ion exchange resin, while the substances which interfere with the GLC 
analysis pass through the ion exchange column. The amino acids are then 
eluated from the column with ammonia, derivatized to their N-trifluoro-
acetyl derivatives, and analyzed by GLC. The ion-exchange clean-up steps 
require at least 30 minutes and additional time is needed to pack and 
prepare the resin column. In actual practice, about 0.1 ml of a serum 
sample is required and the final ion-exhcange eluate is about 3-4 ml. 
Since the eluate has to be collected and evaporated to dryness, a further 
20-30 minutes is required before the sample can be derivatized for GLC. 
It is obvious that this is not entirely suitable for routine clinical work. 
During the last five years, research efforts have been directed 
toward increased speed and simplification of the GLC procedure for the 
quantitative analysis of amino acids. One column methodology and simple 
(32,33,34,35,36) 
derivatization procedures have been tried for these purposes . 
but all attempts to further simplify the derivatization process have been 
unsuccessful. On the other hand, time consuming clean-up procedure can be 
eliminated if a nitrogen detector is used for GLC, as such a detector only 
responds to organic nitrogen compounds, and thus a quantitative measure-,(37,38,39) 
ment of the amino acids is more readily made on the chart record 
A 20 jil sample of plasma is sufficient for a quantitative amino acid 
. . (40) analysis 
The advent of amino acid analysis by means of GLC combined with mass 
fragmentography has also eliminated the need for complete chromatographic 
resolution of the amino acid derivatives. The analytical system required 
consists of a gas chromatograph interfaced with a mass spectrometer which 
is used as a specific ion detector. Summons et al.̂ "̂ ^̂  have reported the 
determination of 12 amino acids in biological fluids by GLC-mass frag-
mentography. A quantitative amino acid determination could be made on 
50 yl of plasma or urine and as deuterated amino acid were used as internal 
standards complete derivatization of the sample was not required. Abramson 
and co-workers^^^^ demonstrated an assay of plasma amino acids by a 
simpler approach. In this method, the retention time as well as char-
acteristic ion fragments of the compounds in the mass spectra were used to 
identify and quantitize the amino acids. More recently, tissue levels of 
glutamic acid and y-amino butyric acid were also quantitatively determined 
by GLC-mass f r a g m e n t o g r a p h y T h e references cited above clearly in-
dicate that the GLC-MS analysis of amino acids is a valuable analytical 
technique for the quantitative estimation of small amounts of amino acids 
in biological fluids, but the complexity of the instrumentation makes such 
a system quite unsuitable for routine clinical work. 
The use of ion-exchange chromatography for the analysis of fatty acids 
and other lipid metabolites, e.g., sterols, has not been particularly 
successful because most of these compounds are only sparingly soluble in 
an aqueous media. Thus, most published analytical methods for these 
metabolites have involved chromatographic separations in a non-aqueous 
media. Paper, thin layer and gas chromatography have been used for this 
purpose, but of these only GLC has been applied for the quantitative 
analysis of fatty acids and steroids. 
Gas liquid chromatography is already widely used for analysis of 
fatty a c i d s a n d the technique is more frequently used in the clinical 
laboratory for the determination of free fatty acid (FFA) levels in 
plasma. 
Individual FFA can be determined by GLC as their methyl ester or 
trimethylsilyl esterderivatives. Depending on the origin of the 
sample the GLC method often requires lengthy sample extraction and other 
chromatographic separations prior to the derivatization step. For example, 
Ko and Royer^^^^ have recently reported a procedure for individual FFA in 
plasma, in which the FFA were extracted into an organic phase after which 
they were purified with silicic acid prior to derivatization. The 
derivatization of fatty acids can sometimes be avoided for plasma 
(48 49) 
analysis ' , but again the required purification steps are still quite 
time consuming. 
Direct mass spectrometry has been used for a qualitative analysis of 
pure amino a c i d s a n d fatty a c i d s S o m e attempts have also been 
made to qualitatively analyze for FFA content of vegetable oil hydroly-
sates. To date no quantitative determination of FFA or amino acids by 
mass spectrometry without prior separation has been reported. 
We have now developed a novel, direct mass spectrometric amino acid 
analysis and have applied it to distinguish abnormals from normals in a 
genetically oriented screening program. Since chromatographic separation 
is not required, a complete quantitative analysis is possible in a short 
time (about 15 min.). The analysis has also been applied to estimate 
blood fatty acids and cholesterol. It has also been shown that other 
metabolites can be analyzed by this route. 
RESULTS AND DISCUSSION 
One of the time consuming steps often associated with the quantitative 
analysis of biological fluids is the sample "clean up" which is often re-
quired prior to analysis. For example blood, serum or amniotic fluid have 
to be deproteinized and, in some cases, the amino acids or fatty acids have 
to be extracted and derivatized prior to analysis. All these manipulations 
significantly add to the analysis time and make the conventional systems 
unsuitable for routine clinical applications. An alternative approach to 
the handling of blood and serum samples makes use of dried blood or serum 
specimens spotted on filter paper from which the amino acids can be eluted 
for TLC or used directly for bacterial inhibition a s s a y s ^ ^ ^ ' ' U p to 
now, the quantitative determination of amino acids from such a small blood 
sample (ca 5-10 yl) has been rather difficult and none of the published 
methods have been entirely satisfactory for routine clinical use. 
Since direct mass spectrometry has sufficient sensitivity to cope with 
such small sample sizes it was decided to use the dried filter paper disc 
method for this work. We also appreciated the fact that most genetically 
oriented amino acid screening programs rely on a definite quantitative 
follow-up test to clearly distinguish an abnormal from a normal individual 
and our new technique was to be suitable for this purpose. Preliminary ex-
periments with dried filter paper blood spots showed that an 80% ethanol 
treatment is sufficient to extract all the free amino acids from the paper. 
During this extraction the blood proteins are denatured and are retained by 
the filter paper. After removal of the filter disc, followed by evaporation 
of the solvent, the dried residue is in a suitable form for derivatization 
and mass spectrometry. 
Free amino acids have already been analyzed by direct mass spectrometry 
without prior derivatization. In general, however, the high temperatures 
required for volatilization lead to dehydration, decarboxylation and de-
amination of some of the amino acids and thus the mass spectra show a low 
abundance of the molecular ions (less than 1% in some cases) 
Our experiments on underivatized amino acids confirmed these observations 
and we found it impossible to use this approach for the quantitative 
analysis of amino acids. 
There are comprehensive reviews about the preparation of volatile 
derivative of amino a c i d s ^ ^ ^ ' ^ ^ ' ' ^ ^ ' T h e s e have been aimed at the 
gas-liquid chromatographic separation of amino acids and a wide range of 
suitable derivatives have been developed for this purpose. However, most 
of the proposed methods are very time-consuming and are also difficult to 
apply to all the 20 protein amino acids. Whilst N-trifluoroacetyl n-butyl 
esters of amino acids are the most suitable for GLC analysis, we found them 
rather difficult to prepare as the procedure involves a number of steps. 
In addition the derivatives were unstable to traces of water and were too 
volatile for direct mass spectrometric analysis. 
The advantages of using a simple pyrolytic derivatization approach, 
for example, the conversion of a tetraalkyl ammonium salt of an amino acid 
to its methyl ester in the solid probe of the MS, has been used by Halpern 
et al. and the method has been applied for the sequencing of peptides by 
direct mass s p e c t r o m e t r y ^ ^ ^ T h u s , our earlier attempts were directed 
to the derivatization of amino acids using tetramethyl (or trimethylphenyl) 
(62 63) 
ammonium hydroxide in the presence of an aldehyde or ketone ' . For 
example, the amino acid phenylalanine (I) could be converted to its neo-
pentylidene or acetylacetonyl trimethylanilinium salt by the above proce-
dure. Subsequent pyrolysis of the salt in the solid probe tip of the mass 
spectrometer yielded the corresponding neopentylidene methyl ester deriva-
tive (II) or acetylacetonyl methyl ester derivative (III) which were 
sufficiently volatile for mass spectroscopic analysis. 
R-CH-C00CH3 R-CH-C00CH3 
I • 
R-CH-COOH N NH 
I II » 
NH2 CH CH3-C = CH-CO-CH3 
I 
C(CH3)3 
(I) (II) (III) 
The chemical procedure of this method is relatively simple as the deriva-
tization involves only one step. However, it takes several hours for 
enamine formation to be complete and this is a serious disadvantage for 
any clinical application. 
In later experiments, it was found that acetic anhydride could be 
used in the pyrolytic derivatization procedure instead of the ketones and 
N-acetyl derivatives could be prepared within minutes at room temperature. 
This modification was found to be suitable for all amino acids and could 
be carried out on a micro scale. Shortly afterwards we established, by 
using different alcohols instead of methanol and different quaternary 
bases such as tetraethyl ammonium hydroxide instead of tetramethyl ammonium 
hydroxide, that acetic anhydride-methanol alone was responsible for the 
methylation of the acidic functions and thus the addition of the quaternary 
base was found to be unnecessary and was discontinued. 
Our amino acid procedure now consisted of the derivatization of the 
amino acids with methanol and acetic anhydride at 100° C for 5 minutes. 
One of the advantages of this method is that glutamine and asparagine are 
stable during the derivatization step and can be analyzed as their N-acetyl 
methyl ester derivatives. This seems to be one of the few methods avail-
able to estimate glutamine and asparagine without prior hydrolysis to 
glutamic and aspartic acids. We have already exploited this reaction by 
developing a suitable GLC analysis by this route for glutamine and 
asparagine^^^). 
Preliminary studies on the direct mass spectrometric analysis of 
N-acetyl phenylalanine methyl ester indicated that the technique of 
electron impact (EI) mass spectrometry might be useful for the analysis of 
one or several amino acids in biological samples. The EI mass spectrum of 
N-acetyl phenylalanine methyl ester yielded a molecular ion (M^) at m/e 
221 and a characteristic amine fragment ion (M-COOCH3) at m/e 162. Since 
the (M+) ion intensity was less than 5% of the amine fragment intensity, 
the ion at m/e 162 was used for our initial experiments. For this purpose, 
a fixed amount of deuterated phenylalanine (Phe-D^, 50 n mole) was added 
to the known amounts of phenylalanine (0-100 n mole) and the mixture was 
evaporated to dryness, derivatized and analyzed by direct EI mass spectro-
metry. The ion peak height of phenylalanine (m/e 162) and of phenyl-
alanine-D5 (m/e 167) was measured and averaged, and the ratio of 
phenylalanine/phenylalanine-D^ was obtained for each phenylalanine level 
used. Graphical analysis of the calibration data confirmed the linearity 
of the assay. The technique was next employed with plasma samples 
phenylketonuric patients. In practice, plasma (50 pl) was first de-
proteinized with ethanol (80%) following the addition of appropriate 
amount of phenylalanine-D3 (12.5 n mole) and then the mixture was centri-
fuged and the supernatant was transferred to the reaction vial for 
derivatization and mass spectrometry (Fig. 1). Whilst this approach is 
highly suitable for the analysis of individual amino acid in blood or 
urine, it is difficult to establish interference free characteristic ions 
for all the amino acids known to be present in biological fluids. Thus, 
it seemed pretty obvious that milder mass spectrometric fragmentation 
methods would be more suitable for this type of analysis and it was 
decided to use chemical ionization (CI) mass spectrometry for this purpose 
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Chemical ionization mass spectrometry (CI-MS) was first reported by 
Munson and Field in 1966(65) and has since been used by many investigators 
as an analytical too 1(66).. 
Compared "with the complex fragmentation 
patterns that result from electron impact ionization, the mass spectra 
produced by CI contain very few ions. For each compound there is generally 
a high intensity protonated molecular ion (MH."̂ ) and at best only low in-
tensities fragment ions. The method is thus more suitable for the 
analysis of mixtures, and the amount of each component can be readily 
estimated from its molecular ion intensity. 
CI mass spectra are generated by positively charged reagent gas ions 
(RH+) which produce protonated molecular ions (MH"̂ ) by collision in the 
ion source of the mass spectrometer. If isobutane is used, the t-butonium 
ion (t-C4H9+) which are formed, will induce a proton transfer to other 
molecules in the ion source. Since the t-C4H^ will give the least exo-
thermic proton transfer reaction^^^), the resulting mass spectrum will 
display the least amount of fragmentation. The reaction of t-C4H9+ with 
the sample in the CI source is shown in Fig. 2. 
i-C4Hio + ^ t-C4H9'^ 
M + t-C4H9+ h (MH+) + t-C4H8 
(MH+) ^ M3_+ + M2+ 
Fig. 2. Reactions in the chemical ionization source. 
The energy transfer in this process is very much less than in electron 
impact, and thus less energy is transferred to molecular ion species and 
less fragmentation will result. Fewer fragment ions mean that quantita-
tively most of the molecule is present as a single ion species and thus the 
detectability is greatly increased. 
The published CI mass spectra of free amino acids^^^), with methane 
as the reactant gas, show the protonated molecular ions of each correspond-
ing amino acids and single fragmentation patterns, namely, (MH"̂ ) - H2O, 
(MH+) - COOH^, (MH+) - NH^, etc. These fragmentation patterns can be 
rationalized as arising from decomposition of the molecule protonated at 
several sites. As is clear from these examples, CI-MS should be suitable 
for the analysis of amino acid mixtures. 
Whilst previous workers used methane gas for this purpose, we decided 
to use isobutane as this is known to lead to even less fragmentation. 
The CI (isobutane) mass spectra of N-acetyl amino acid methyl esters ex-
hibited intense protonated molecular ions peaks and unique m/e values were 
obtained for all amino acids with the exception of leucine and isoleucine 
which yield the same protonated molecular ion (Table 1). 
Of the common protein amino acids, glycine, alanine, serine, proline, 
valine, threonine, leucine and isoleucine, methionine, phenylalanine, 
histidine and tryptophan were all converted by acetic anhydride-methanol 
to their corresponding mono-acetyl methyl esters. Aspartic and glutamic 
acids were converted to mono-acetyl di-methyl esters, and asparagine and 
glutamine were in the form of an acetyl mono-methyl ester. Cysteine, 
lysine, tyrosine, arginine and cystine were present as di-acetyl methyl 
ester derivatives. Arginine did not yield a protonated molecular ion at 
m/e 273 but instead intense peaks at m/e 157 (Fig. 3) and m/e 199 were 
present. The identity of these diagnostic peaks at m/e 157 and m/e 199 
were confirmed by two follow-up experiments using (a) methanol and acetic 
anhydride-D^, and (b) methanol-D4 and acetic anhydride as derivatizing 
reagents, respectively. 
The results of the first experiment showed that the peak at m/e 157 
and at m/e 199 were shifted to m/e 160 and m/e 202, respectively. Whilst 
Table 1. Mass spectral data for N-acetyl amino ac id methyl esters 
Amino Acid [M+1]"̂  Amino Acid [M+1]"̂  Other 
Diagnostic Peak 
Glycine 132 Methionine 206 
Alanine 146 Histidine 212 
Serine 162 Glutamic acid 218 
Proline 172 c Cysteine 220 
Valine 174 Phenylalanine 222 
Threonine 176 Lysine^ 245 
Leucine 188 Tryptophan 261 
Isoleucine 188 c Tyrosine 280 
Asparagine 189 Arginine^ - 157^ 
Glutamine 203 c Cystine - 176,178'' 
Aspartic acid 204 
^[NH^ (CH^) ̂ -CHCNHCOCH^) CO]"̂  
^[S-CH2-CH(NHC0CH^)C00CH^]"^ and [HS-CH^-CHCNHCOCH^) COOCH^]"^ 
Q Diacetyl derivative 
in the second experiment, the intense peaks remained at m/e 157 and 
m/e 199. 
NH 157 H 
-N-CH2-CH2-CH2-CH-CO f 0-CH3 
Fig. 3. Fragmentation of arginine molecule. 
The spectrum of N,N di-acetyl cystine methyl esters exhibit two 
characteristic peaks, e.g., m/e 176 and m/e 1 7 8 , which are derived from 
the breakage of the di-sulfide (s—s) bond followed by proton loss or 
gain(68). 
These results demonstrated that the N-acetyl amino acid methyl 
esters are suitable derivatives for direct C I mass spectrometry. Our next 
step was to establish whether a suitable quantitative analysis could be 
developed. The use of stable isotopically labelled standards for quanti-
tative C I mass spectrometric analysis has already been e s t a b l i s h e d C ^ ^ , 7 0 , 
and thus we decided to use a similar approach for our problem. Stable 
isotope labelled amino acids are commercially available and some of them 
were obtained and some were prepared by published methods. 
In our first experiments, standard solutions of phenylalanine, 
tyrosine, valine, glycine, aspartic acid and glutamic acid and their cor-
responding internal standard phenylalanine-D3, tyrosine-D2, valine-D^, 
glycine-D2 or glycine-l^N, aspartic acid-l^N and glutamic acid-15N were 
analyzed individually by direct CI mass spectrometry. Later, a series of 
amino acid mixtures and a fixed amount of the isotopically labelled amino 
acids were used for quantitative calibration. Calibration curves for 
these selected amino acids were then determined by comparing the protonated 
molecular ion peak height of a concentration range of unlabelled amino 
acids with that of the appropriate isotopically labelled amino acid. This 
was done by a manual method in which 5 M.S. scans were recorded on U.V. 
sensitive chart paper and the mean peak height ratio were compiled 
(Fig. 4). The slopes of the calibration lines were then used to calculate 
the calibration factors which correct the results for the chemical and 
isotopic purity of the internal standards. If ^^N amino acids are used as 
internal standard, correction should be made for the natural abundance of 
13 
C (1.08%) and D (0.016%) isotopes, as the internal standard signal will 
be enhanced by these contributions of the unlabelled amino acid. In 
practice, we have found that if calibration and sample measurements are in 
the same concentration range correction is not necessary. This has been 
done in experiments using ^^N-glycine, ^^N-leucine, ^^N-aspartic acid, and 
^^N-glutamic acid. A similar adjustment is also necessary if methionine 
(m/e 206) is analyzed for in the presence of ^^N-aspartic acid (m/e 205). 
More recently we have also used a computer to record spectral data and to 
calculate the mean value and standard deviation. In this mode we usually 
recorded ten or more measurements for each analysis (Figs. 5 and 6). The 
technique was then applied to the analysis of a commercially available 
amino acid mixture containing 1 n mole/ul of each amino acid. The results 
shown in Table 2 are the means and standard deviations obtained from four 
separate analyses and are expressed in n mole per ]il. Iî  ̂ H cases, the 
standard deviations were less than 2% of the mean. This compares favorably (A-X A2 A"3) 
with GC-MS mass fragmentographic analyses currently in use ' * • Under 
routine operating conditions, 25 nanogram of an amino acid is sufficient for 
a quantitative analysis. The linearity of the assay was further confirmed 
by repeating the calibrations on artificially prepared blood spot amino acid 
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Fig. A. Calibration curves obtained from an amino acid mixture 
containing Asp, Asp^^N, Glu, Glu-^^N, Gly, Gly-D2, Phe, 
Phe-Dj, Tyr, Tyr-D2, and Val, Val-Dg. 
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Fig. 6. Computer print out of peak height ratio (m/e 132 vs 134, and m/e 222 vs 227) for 
the calibration of glycine and phenylalanine using deuterium labelled glycine (D2) 
and phenylalanine (D^) internal standard, respectively. 
Table 2. Amino acid analysis by chemical ionization 
mass spectrometry 
Amino Acid Mixture (1 n mole/yl) 
Amino Acid 
Mean^ + S.E.M.^ 
Gly 1. ,04 0. ,02 
Val 1. ,00 0. ,01 
Asp 1. ,06 0. .02 
Glu 1. .04 0. .02 
Phe 0. .96 0. .01 
Tyr 1, .03 0, .02 
Average of four analyses 
^S.E.M. = Standard Error of Mean 
solutions (Figs. 7 and 8). The experiments were carried out by using 
samples of whole blood to which additional phenylalanine, glycine or valine 
respectively had been added to produce amino acid concentration ranges of 
0-15 nanomole. To determine recoveries of amino acids from the blood 
spot samples, we used blood spots (5 ]il) supplemented with amino acid 
standards (5 n mole), and extracted, derivatized, and analyzed the samples 
by CI-MS. The increase or decrease^in peak height ratios (unlabelled to 
labelled) of the blood amino acid were compared to the peak height ratios 
obtained from a control experiment using unspiked blood spots to which 
amino acids (5 n mole) were added at the extraction stage of the analysis. 
The results are given in Table 3. The recoveries were close to 100% with 
a coefficient of variation of 2-3%. 
The next step was to apply this new microanalytical method to the 
analysis of small samples of blood from a genetic screening program. This 
was most conveniently done by using blood samples which has been spotted 
on filter paper. For the analysis, we used a punch (4 mm diameter) which 
contains 5.5 yl blood and the blood amino acids were extracted with 80% 
ethanol containing the appropriate labelled amino acids. The mass spectra 
were then recorded and the concentration of the amino acids in the blood 
were calculated. 
Fig. 9 shows the mass spectral profile obtained from a normal control 
and from a patient suffering from phenylketonuria (PKU). These spectra 
were compiled by taking five mass spectral scans and manually measuring 
the peak heights of the Mh"'" ions of phenylalanine-D^ (m/e 222) and 
phenylalanine-D^ (m/e 227) for each scan. The peak height ratios (Phe-D^ 
vs. Phe-D^) were then calculated and the average value was used for the 
final calculation of amino acid concentration. In this way we calculated 
the Phe value (Fig. 9) in the control sample to be 1.9 mg % and the Phe 
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Fig. 7. Calibration curve for the quantitative determination of phenylalanine. 
Whole blood was supplemented with phenylalanine to produce concentra-
tions of 0 to 15 n mole per 5 \ll dried blood spot. A fixed amount of 
labelled phenylalanine (10 n mole) was used for each analysis. The 
peak height ratios (Phe m/e 222 vs Phe-D5 m/e 227) were determined 
from the mass spectra. The composition of the labelled Phe used was 
4% DQ-, 2.7% Di-, 4% D2-, 13.5% D3-, 29% D4-, 37% D5-, 7% D^-, and 
2.8% Dy. 
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Fig. 8. Calibration curve for the quantitative determination of 
glycine and valine. Whole blood was supplemented with 
glycine and valine to produce concentration of 0 to 5 n 
mole per 5 yl dried blood spot. A fixed amount of la-
belled glycine and valine (10 n mole) was used for each 
analysis. The peak height ratios (Gly m/e 132 vs 
Gly-D2 m/e 134; and Val m/e 174 vs Val-D5 m/e 180) were 
determined from the mass spectra. 
Table 3. Recoveries of amino acids added to blood spots. Standard amino 
acids (D^, 5 n mole) were added to whole blood prior spotting. 
The blood spots were punched, amino acids were extracted with 
80% ethanol solution. Immediately prior to the removal of the 
filter paper blood disc a known amount of labelled amino acid 
standards (D^, 10 n mole) were added. Peak height ratio were 
computed and the results were compared with that of control 
samples with added D^ after extraction. 
Amino 
Acids 
Blood Spot 
+ 
Amino Acid 
(kA/AA*)^ 
Blood Spot Extract 
+ 
Amino Acid 
(AA/AA*) 
Recovery, C.V., 
Gly 1.23 1.26 98 3.1 
Val 0.69 0.71 97 2.8 
Asp 0.55 0.54 101 2.2 
Glu 0.47 0.51 92 2.3 
Phe 1.50 1.55 97 2.0 
Tyr 0.56 0.60 93 2.1 
^Average of five analyses 
Coefficient of variation 
^Unlabelled to labelled amino acid ratio 
10(2) (Z) 
w 
PQ < 
w > M 
5 0 0 C\J 
Q 
I 
O > 
o 
CD 
D 
• (a) 
Normal Control 
IT) 
D 
I (D 
D. 
0) 
CL 
C\J 
Q 
V. 
M 
tS CD 00 CJ 
Si 
OJ 
OJ 
-J-
CJ 
© 
CD 
CJ 
tSi 
CO 
OJ 
M/E 
Fig. 9. The c.i. (isobutane) mass spectral profiles of 5 yl blood spots obtained from 
(a) normal control and (b) patient suffering from phenylketonuria (PKU). 
w CJ 
c 
c 
w > 
M Eh 
W 
500 _ 
(b) 
Phenylketonuria 
CD JZ Cl-
io 
Q I 
0) 
CsJ 
Q I 
U) o 
cs 
CD CO 
(3 
O J 
tS 
OJ 
OJ 
© -j-
OJ 
CO 
Co 
g M/E 
OJ 
Fig. 9. The c.i. (isobutane) mass spectral profiles of 5 yl blood spots obtained from 
(a) normal control and (b) patient suffering from phenylketonuria (PKU). 
level of the PKU sample to be 20.2 mg %. 
We further checked our analytical technique by analyzing four PKU 
blood spot samples five times each and comparing our data with the results 
obtained from classical ion-exchange chromatography (Table 4). The good 
reproducibility and the excellent agreement of our blood spot analyses 
with the corresponding ion-exchange plasma amino acid analyses suggests 
that the new technique accurately determines the free Phe content of the 
plasma. 
In other experiments, we compared the M.S. blood spot phenylalanine 
analyses with results obtained from the semi-quantitative bacterial assay-
(54) 
Guthrie test (Table 5). This was done using four control Guthrie 
blood spot specimens in duplicate. Each of the blood spot disc was ex-
tracted with 80% ethanol containing 12.5 nanomole phenylalanine-D^. The 
mass spectra (5 scans per analysis) were then recorded and the concentra-
tion of phenylalanine in the blood were calculated. We also established, 
by doing the blood spot analysis on several one-year old Guthrie blood 
spot specimens, that the amino acid content of those samples was quite 
stable upon storage. 
We have also shown that other inherited diseases such as maple syrup 
urine disease (MSU), hyperglycinemia and tyrosinemia can be diagnosed from 
the blood spot mass spectral profile (Figs. 10, 11 and 12) as in each case 
abnormal quantities of one or more amino acids are shown to be present. 
Under routine operating conditions it has been established that the 
specificity of the new technique permits the determination of all the 
common blood amino acids down to a level of 25 n moles, whilst still 
maintaining a signal to noise ratio better than 10:1. Other low molecular 
weight blood constituents such as cholesterol, fatty acids and organic 
acids, show ions in the mass spectra but do not interfere with the 
Table 4. Phenylalanine analyses of Phenylketonurie blood and plasma 
by mass spectrometry and ion exchange chromatography 
Patient 
Mass Spectrometry (blood spot) 
Concentration Mean + S.E.M. 
(mg %) (mg %) 
Ion Exchange (plasma) 
Mean^ 
(mg %) 
G.L. 18.24 
18.10 
18.68 18.53 + 0.30 18.81 
18.53 
18.83 
F.T. 20.89 
20.60 
20.45 20.60 + 0.25 20.30 
20.74 
20.30 
W.M. 14.86 
15.16 
15.01 15.01 + 0.29 15.80 
14.57 
15.30 
S.S. 12.80 
13.39 
13.09 13.09 + 0.24 13.04 
12.95 
13.24 
S.E.M. = Standard Error of Mean 
Average of two analyses 
Table 5. Phenylalanine analyses of Guthrie blood spot by CI mass 
spectrometry and Guthrie bacterial inhibition assay 
CI-MS Method Guthrie Assay Sample 
(mg %) (mg %) 
A 6.70 6.73 7 
B 5.54 5.55 6 
C 7.06 7.10 6 
D 5.97 5.97 6-8 
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quantitative amino acid analyses. For example, small amounts of 03̂ 2-0 
^20:0 fatty acids are extracted aqueous alcohol from the blood spot 
and are esterified by acetic anhydride-methanol to yield fatty acid methyl 
esters (Table 6). 
Since we have noticed that the relative intensity of all the blood 
amino acid in normal specimens is fairly constant, it is often possible to 
detect an unexpectedly high abundance of an amino acid or the presence of 
an unusual amino acid even without the addition of a labelled standard 
(Figs. 13 and 14). 
We then decided to apply this new analytical technique to the 
analysis of other physiological fluids, such as plasma, serum, urine, 
amniotic fluid, and saliva. For the analysis of plasma and serum, a 
deproteinization step is required, but urine, saliva or amniotic fluid can 
be used directly for the analysis. 
Again the CI-MS results from 6 PKU plasma samples were compared with 
those obtained by ion-exchange chromatography (Table 7). The good re-
producibility and the excellent agreement of the data with the correspond-
ing ion-exchange method shows that the new technique accurately determines 
plasma phenylalanine levels. 
Similar experiments were also carried out with tyrosine, glycine and 
valine as abnormal plasma levels of these amino acids are also indicators 
of other hereditary disorders such as tyrosinosis, hyperglycinemia and 
maple syrup urine disease. Table 8 shows the amino acid concentration 
determined By CI-MS for a normal, tyrosin^^ic, hyperglycinemic and 
maple syrup urine affected plasmas. The results shown are the average 
obtained from two separate analyses and are expressed in mg/100 ml plasma. 
Table 6. Protonated molecular ions (MH*^) for biological important 
fatty acids derivatized as methyl esters by acetic 
anhydride-methanol reagent 
Fatty Acid (MH"'') 
^ 2 : 0 215 
^14:0 243 
^16:0 271 
^ 6 : 1 209 
4 8 : 0 299 
^18:1 297 
^18:2 295 
^18:3 293 
^20:0 327 
S 0 : 4 319 
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Fig. 13. The c.i. (isobutane) mass spectral profile of a blood spot obtained 
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Table 7. Phenylalanine analyses of phenylketonuria plasma by 
mass spectrometry and ion exchange chromatography 
Patient No 
Mass Spectrometry 
(Mg %) 
Ion Exchange Chromatography^ 
(Mg %) 
1161 12. 91^ 0. 24^ 12. 54^ 
1162 18. ,86 0. 31 18. 15 
1163 15. .91 0, ,27 15. 35 
1164 16. .26 0. ,28 16. 14 
1165 15, .84 0. .27 15. ,82 
1166 15, .56 0. .29 15. ,51 
^Analysis was conducted by L. B. James, John Curtin School of Medical 
School, A.C.T. 2601, Australia 
Average of three analyses 
^Standard Error of Mean 
^Average of two analyses 
Table 8. Amino acid plasma levels for tyrosinesis, hyperglycinemia, 
and maple syrup urine disease (mg %) 
Disorder Amino Acid Patient Normal Control 
Tyrosinosis 
Hyperglycinemia 
(Pre-exchange) 
(Post-exchange) 
Tyr 
Phe 
Gly 
Gly 
21.55 
1.22 
14.15 
5 .62 
(1 .25) 
(1.02) 
(2.11) 
Maple syrup urine Val 20.64 (2 .37) 
In other experiments we analyzed blood phenylalanine/tyrosine ratios 
which can be used to detect PKU heterozygosity. In these experiments the 
patient was given an oral load (up to 100 mg/kg body weight) of phenyl-
alanine and the Phe and Tyr plasma level was monitored and the Phe/Tyr 
ratio calculated. The results from these experiments are summarized in 
Table 9. The results show that the phenylalanine plasma profiles of an 
heterozygote can be distinguished from that of a normal individual 
(Fig. 15). 
The method was also applied to the analysis of human saliva, amniotic 
fluid and urine specimens. In each case fifty microliter samples of 
these biological fluids are required. For example, saliva was collected 
from five male subjects in good general health between the ages of 25-30. 
Before sample collection, the subjects were required to rinse out the oral 
cavity with distilled water several times. Samples of saliva were obtained 
by expectoration into glass beakers, and the samples were pooled for 
analysis. The mass spectral analyses of amino acids from five runs of 
pooled saliva samples are summarized in Table 10, and indicate the re-
producibility attainable for these types of samples. No published data 
for saliva amino acids are available, so it was not possible to compare our 
results with published values. 
A comparison of phenyalanine saliva levels in two PKU patients with a 
normal was also made. The results show that the Phe content of the patient 
was four times that of a normal (Table 11). This is not as high as the 
levels found in blood (30 times normal) and thus saliva does not seem 
particularly suitable for PKU diagnostic purposes. 
Similar experiments were also carried out using samples of amniotic 
fluids. Fifty micro-liter of pooled amniotic fluid were used for this 
Table 9. Plasma levels of phenylalanine and tyrosine, and phenylalanine 
to tyrosine ration in PKU heterozygote 
Time-course Phe Tyr Phe/Tyr Ratio 
(Mg %) (Mg %) 
Before Phe load 1.03 1.05 0.98 
After Phe load 
1 h 10.28 2.33 4.41 
2 h 6.39 1.45 4.40 
4 h 4.27 1.25 3.42 
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Fig. 15. Phenylalanine loading test. Phe/Tyr ratio vs 
time after the load. 
Table 10. Physiological amino acids levels of saliva and amniotic 
fluid. Normal adult and pregnant subjects were used 
for the complete procedure. 
Saliva Amniotic Fluid 
Amino Acids 
Mg % c.v., % Mg ^ ! C.V., % 
Gly 0.47^ 2.3^ 1.11^ (0.9-1.3)^ 2.5'' 
Val 1.33 1.9 0.72 (0.5-2.3) 2.1 
Asp 0.37 2.1 0.50 ( — ) 2.0 
Glu 0.44 1.9 1.21 (1.1-3.3) 1.8 
Phe 0.52 1.7 0.68 (0.3-1.2) 1.9 
Tyr 0.52 1.9 0.47 (0.3-1.3) 1.8 
^Average of five analyses 
'c.V. = Coefficient of Variation 
'Reference No. 72 
Table 11. Phenylalanine analysis of PKU saliva 
and plasma by mass spectrometry 
Patient 
PKU Saliva PKU Plasma 
(Mg %) (Mg %) 
S.L. 2.41^ 27.82^ 
M.V. 2.36 29.28 
Normal control 0.52 1.10 
Average of two analyses 
purpose and the results for some amino acids are summarized and compared 
with the published data (Table 10). 
For the analysis of urine a 24-hour urine was obtained from three 
normal male subjects. These were pooled and derivatized and analyzed by 
CI-MS. The relative peak height values of the urinary amino acids in 
this sample are shown in Table 12. It was noted that a molecular ion peak 
for creatinine at m/e 156 and for hippuric acid at m/e 194 were also pre-
sent in the spectrum. This suggests that suitable MS techniques for the 
quantitative analysis of these metabolites will be possible provided 
labelled internal standard can be prepared. 
At the time of writing, we have confirmed the suitability of the 
analysis for most protein amino acids with the exception of serine, 
threonine, histidine, cysteine, cystine and arginine. Labelled standards 
of some of these amino acids are being prepared, and some are being ob-
tained from commercial sources. 
The possibility of using commercially available stable isotopically 
labelled algal protein hydrolysate as internal standard is also being 
examined. 
In view of our success with the blood amino acid analysis, we looked 
at the possibility of analyzing for other blood metabolites by the same 
approach. 
The literature suggests that a mixture of chloroform and methanol in 
the ratio of 2:1 (v/v) will extract lipid more exhaustively from biologi-
cal materials than most other simple solvent systems and we have confirmed 
that sonication with this solvent mixture extracts fatty acids, 
cholesterol and triglycerides from the blood spot. 
Table 12. Relative peak height values of amino acids found in human 
urine by c.i. mass spectrometry. Normal adult subjects, 
pooled of three, were used for the complete procedure. 
Values represent an equivalent to 15 ]il urine. 
(QH) + Compound Temperature of Solid Probe 
70° C. 120° C 180° C 
Peak Height (mm) 
132 Gly 43 33 3 
146 Ala 93 7 3 
a 
174 Val 10 6 4 
188 Leu + H e 9 3 1 
b 
204 Asp 11 24 3 
206 Met 34 6 1 
230 Hpr 35 46 1 
245 Lys 5 7 11 
^(QM) = 156. Creatinine (peak heights 120-280) 
(̂QM)"*" = 194. Hippuric acid (peak heights 9-110) 
Preliminary experiments with individual free fatty acids showed they 
could be readily detected by CI-MS at solid probe temperatures between 
100-200°C. The CI mass spectra of the saturated and the unsaturated free 
fatty acids were dominated by large protonated molecular ion peaks (MH+) 
and unique m/e values were obtained for all biologically important fatty 
acids in the range Cx2:0 to C20:0 (Table 13). 
For quantitative work, we decided to use deuterium labelled fatty 
acids as internal standard. These were difficult to obtain from commer-
cial sources and thus the preparation of some labelled fatty acid standards 
was necessary. The literature contains a number of approaches on the 
preparation of deuterium labelled fatty a c i d s , 7 4 ) ^ Xhe published 
methods use platinum and basic conditions at elevated temperatures. Our 
results using this method were disappointing as it was difficult to con-
trol the level of deuterium incorporation. Another published approach to 
labelled fatty acids uses D2SO4 as a c a t a l y s . By a slight modifica-
tion of this technique in which we used (CD3CO)20 to solubilize the fatty 
acids in the reaction mixture we are able to produce a-labelled D2 fatty 
acids. This new procedure was experimentally quite simple and up to 93% 
D2 incorporation could be obtained using incubation at 160°C overnight. 
The mass spectra of the labelled compounds were recorded and the 
isotopic composition of the labelled fatty acids was determined by M.S. 
Table 14 shows the percent of D incorporation into the labelled fatty 
acids prepared by this route. The individual deuterated fatty acid 
standards were then combined into one standard chloroform solution. 
Our attempts to label unsaturated fatty acids such as C^^.i or Ci8:l 
by this route were not successful and therefore our initial quantitative 
work was confined to the saturated fatty acids. 
Table 13. Chemical ionization mass spectral data 
for free fatty acids 
Fatty Acid (MH)"'' 
Laurie ^12*0 ^^^ 
Myristic ^14:0 ^^^ 
Pantadecanoic ^15-0 
Plamitic ^16:0 ^^^ 
Palmitoleic 255 
Stearic ^18:0 ^^^ 
Oleic ^18:1 ^^^ 
Linoleic ^18*2 ^^^ 
Linolenic ^18*3 ^^^ 
Arachidic ^20*0 ^^^ 
Arachidonic ^20-4 ^^^ 
Phytanic ^20:0 ^^^ 
Table 14. Chemical ionization mass spectrometry of prepared 
a-deutero fatty acids 
Fatty Acid D^ % 
(peak height) 
Laurie acid ^^ 
Myristic acid Q) 0.10 91 
Palmitic acid (C^^.Q^ 0-13 88 
Stearic acid (C^g.Q^ 0-16 86 
Phytanic acid (^29-0^ 0.10 91 
In our first experiments, different quantities of a reference solution 
of fatty acids containing lauric acid (Cx2:0)) myristic acid (03^4.0), 
palmitic acid (CI^^.Q) stearic acid (C^^g.Q) and a fixed amount of the 
internal standards (lauric acid-D2, myristic acid-D2, palmitic acid-D2 and 
stearic acid-D2) were mixed and concentrated and introduced into the M.S. 
Calibration curves for these fatty acids were then determined by comparing 
the protonated molecular ion (MH"̂ ) peak height of a concentration range of 
unlabelled fatty acids with that of the appropriate isotopically labelled 
fatty acid. Graphical analysis of the data confirmed the linearity of the 
assay (Fig. 16). The slopes of the calibration line were then used to 
calculate the calibration factor which corrects the results for the 
chemical and isotopic purity of the internal standards. The technique was 
then applied to the analysis of a synthetic fatty acid mixture and the re-
sults were compared with the data obtained from a gas-liquid chromatographic 
analysis of the same mixture (Table 15). The good reproducibility and the 
excellent agreement of our analysis with the corresponding gas-liquid 
chromatographic analysis suggests that the new technique accurately deter-
mines the free fatty acid content of the mixture. 
We further checked our analytical technique by analyzing an artifi-
cially prepared blood sample supplemented with different amounts of stearic 
acid. For the analysis, the blood spots were extracted with CHCl3-MeOH 
containing a fixed amount of stearic acid-D2 as internal standard. The 
mass spectra were then recorded and the concentration of the stearic acid 
in the blood was calculated. These spectra were compiled by taking five 
mass spectral scans and manually measuring the peak heights of MH+ ions of 
Cl8:0 285) and C^siO'^Z ^^^^ ^^^ ^^^^ 
ratios (m/e 285 vs. m/e 287) were then calculated and the average value 
was used for the final calculation of Ci8:0 concentration in the blood. 
Free Fatty Acid ( ^ g ) 
Fig. 16. Calibration obtained from a fatty acid 
mixture containing lauric acid, lauric 
acid-D2, myristic acid, myristic acid-D^ 
palmitic acid-D2, and stearic acid, 
stearic acid-D2. 
Table 15. Analysis of fatty acid mixture by chemical ionization 
mass spectrometry and gas chromatography 
Fatty Acid Mass Spectrometry Gas Chromatography 
w/w S.D.^ w/w S.D.^ 
^12:0 18.66 0.56 18.41 0.64 
^4:0 17.91 0.52 18.11 0.62 
^6:0 35.45 0.96 35.80 1.10 
^18:0 27.99 0.78 27.68 1.02 
Average of five determinations 
^Standard Deviation 
The linearity of the assay (Fig. 17) indicated that the blood spot 
technique was suitable for the analysis of various levels of Cj^g.Q and 
similar results were also obtained for C J^^.Q and C]^5.o acids. 
The technique was then employed to determine the free fatty acid 
components of blood spotted on filter paper (Table 16). This was done 
with one blood spot disc containing 5.5 PI blood and the blood fatty acids 
were extracted with CHCl3-MeOH containing the appropriate labelled fatty 
acid standards. The extract was then concentrated and analyzed by CI-MS. 
Again, peak height ratio of 5 scans were obtained and average value was 
used for final calculation of free fatty acid concentration. 
The next step was to apply this new microanalytical method to the 
analysis of small samples of blood from a genetic screening program for 
disorders of fatty acid metabolism such as Refsum's disease. 
In the patient with Refsum's disease there is an accumulation of 
exogenously derived phytanic acid, a C20:0 branched chain fatty acid 
namely 3,7,11,15-tetramethylhexadecanoic acid, in the tissue and serum of 
the patient. In our first experiment we prepared deuterated phytanic 
acid-D2 by the same procedure as described previously. By using a fixed 
amount of phytanic acid-D as internal standards, a calibration curve for 
phytanic acid was established for the expected concentration range. 
Graphical analysis of the data again confirmed the linearity of the assay 
(Fig. 18). In later experiments, we also confirmed the linearity for an 
artificially prepared blood sample supplemented with different amounts of 
phytanic acid and this calibration curve was found to be identical with 
the standard calibration curve. These results suggested that normal blood 
contains negligible amounts of C20:0 ^cids. This is not the case for a 
blood spot sample from a patient suffering from Refsum's disease. This 
yielded a significant (MH+) at m/e 313 for phytanic acid (Fig. 19) and the 
2.0 3.0 
Stearic Acid Ĉ g.o (pg) 
Fig. 17. Calibration curve for the quantitative deter-
mination of stearic acid in blood. Blood was 
supplemented with stearic acid (0̂ 3.q, MW=284) 
to produce concentration of 0.5, 1.0, 2.0 and 
3.0 yg per 20 yl dried blood spot. A fixed 
amount (2 yg) of stearic acid-D (C13.0, MW=286) 
was used for each analysis. 
Table 16. Analysis of blood spots by chemical 
ionization mass spectrometry 
Fatty Acid^ 
Patient A Patient B 
Mg S.D." Mg S.D.^ 
^12:0 
0.24 0.01 0.39 0.01 
^14:0 
2.00 0.06 2.15 0.05 
^16:0 
10.44 0.29 8.69 0.25 
^ 8 : 0 
3.48 0.09 3.04 0.08 
a 
Plasma free fatty acids have been determined by gas chromatography. The 
The literature (48) suggests that the levels are from 1.0-2.8 mg % 
(C^^.q), 0.4-11.3 mg % (C^^.q) and 0.2-3.9 mg % ( C ^ ^ g . Q ) . 
^Average of five determinations 
^Standard Deviation 
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Fig. 19. The c.i. mass spectral profile of a blood spot from (a) a normal control and (b) a 
patient suffering from Refsum's disease. 
concentration of this acid in the blood of the patient was shown to be 
16.40 + 0.46 mg 
CI-MS permits the determination of all common free fatty acids in 
blood down to a level of 25 ng at a signal/noise ratio better than 10:1. 
Other low molecular weight blood constituents such as cholesterol, cho-
lesterol esters, triglycerides and other organic acids which may be present 
in the mass spectra do not interfere with the analysis. Underivatized 
amino acids, peptides and other blood constituents are either insoluble 
in the extraction solvent or not sufficiently volatile for direct mass 
spectrometry. 
We next looked at the possibility of determining blood cholesterol by 
this method. When cholesterol was exposed to t-C4H9+ ions in the mass 
spectrometer at a probe temperature of 140-160°C most of the cholesterol 
was dehydrated and the base peak of the mass spectrum was at m/e 369 
(Fig. 20). The other peaks in the spectrum were at m/e 387 (4.5%), 
m/e 386 (4.5%), and m/e 486 (9.1%) which correspond to (MH)*̂ , (M)+, and 
(M-H)^, respectively. 
For quantitative work, deuterated cholesterol was prepared according 
to a published procedure(76) and the sample prepared by us contained 
(4%), D2 (12%), D3 (24%), D4 (32%) and D5 (28%) as shown by MS analysis 
(Fig. 20). 
For calibration purposes, a fixed amount of labelled cholesterol 
(1.0 yg) was added to varying amounts of a reference cholesterol solution 
and the peak height ratios at m/e 369 and m/e 373 were monitored. 
Graphical analysis of the data confirmed the linearity of the assay 
(Fig. 21). 
It was also possible to establish the calibration curve, but at a 
reduced sensitivity, by comparing the sum of the peak heights of the (M)" 
(a) (b) (c) 
373 369 
+ 
MH 
387 
X jl 
(MH'^-H20) 
369 
(MH'^-H20) 
373 
MH"^ 
391 
390 
385 
390 380 370 360 m/e 390 380 370 360 m/e 390 
— « — 
380 
ON U) 
370 360 m/e 
Fig, 20. The c.i. (isobutane) mass spectral analysis of (a) cholesterol, (b) choles-
terol-D^^ and (c) cholesterol + cholesterol-D^^ (1:1 w/w) . 
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Fig. 21. Calibration curves for the quantitative determination 
of cholesterol, A fixed amount of deuterated choles-
terol (1 Ug) was used as internal standard for each 
analysis. 
and (M-H)"^ at m/e 386 and m/e 385 to that of the corresponding labelled 
standard at m/e 390 and m/e 389. The cholesterol standard curve (dehy-
drated peaks) was then used to calculate the calibration factor which 
corrects the results for the chemical and isotopic purity of the internal 
standards. 
The linearity of the assay was further confirmed by repeating the 
calibrations on artificially prepared blood spiked with cholesterol 
(Fig. 22). The experiments were then carried out using whole blood to 
which additional reference cholesterol had been added so that the 5 yl 
blood spot samples contain a concentration range of 0-10 yg of cholesterol. 
For the analysis, the blood spot was extracted with CHCI3 - MeOH (2:l,v/v) 
reagent containing a fixed amount (5.0 yg) of labelled cholesterol. The 
mass spectra were then recorded at probe temperature 150 + 10°C and the 
concentration of the cholesterol in the blood was calculated. As pre-
viously this was done by taking five mass spectral scans and manually 
measuring the peak heights at m/e 369 and m/e 373 for each scan and 
averaging the result. The effect of the presence of cholesterol esters on 
the assay was then checked by adding cholesterol esters, e.g., cholesteryl 
palmitate and cholesteryl stearate (10.0 yg each) to the blood. The re-
sults of these experiments showed that our procedure only measure "free" 
cholesterol. 
The method was then used to analyze free cholesterol in normal blood. 
For this a 5 yl blood spot disc (4 mm diameter) was punched out and the 
cholesterol and other lipids were extracted with CHCI3 - MeOH containing 
the appropriate labelled cholesterol standard (5.0 yg). Table 17 shows 
the CI-MS and thin layer chromatography analytical results on several 
blood cholesterol samples. The free cholesterol data indicate good 
agreement between the CI-MS and the TLC methods(77). 
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Fig. 22. Calibration curve for the quantitative determination of 
cholesterol in blood. Blood was supplemented with choles-
terol to produce concentration of 0 to 10.0 ]Jg per 5 yl 
dried blood spot. A fixed amount (5 Ug) of cholesterol-04-
was used for each analysis. The dehydrated ion peaks of 
cholesterol at m/e 369 and of cholesterol-D4 at m/e 373 
were used for the determination of peak height ratio. 
Table 17. Comparison of blood analysis for free cholesterol, 
as obtained by mass spectrometry and thin-layer 
chromatography 
Blood Sample Free Cholesterol (mg %) 
^^ ^^^ Mass Spectrometry^ TLCb 
1 58.5 58.2 58.9 
2 67.0 66.6 65.1 
3 55.1 55.7 56.2 
4 75.5 75.0 74.3 
5 60.8 61.6 62.0 
^Deuterium labelled cholesterol (ca. 5 Ug) was used as internal standard 
Solid probe temperature was at 150 + 10° C. Average of five spectral 
scans was used for each analysis. 
^Average of two analyses 
To evaluate our new method with present day clinical cholesterol 
assays, it was necessary to determine total blood cholesterol as all the 
present methods only determine the latter. To do this we carried out an 
alkaline hydrolysis to release bound cholesterol from its lipoprotein 
complexes and its esters. This was done by heating a sodium methoxide 
(Na/MeOH) solution of the serum containing the internal standard at 100°C 
for 15 minutes. Table 18 shows the mass spectral and enzymatic results^^^) 
for total cholesterol in serum. The results indicate that the serum 
total cholesterol content as determined by the two methods is within 5%. 
Following these experiments, we also evaluated the new blood spot 
analysis for both free cholesterol and total cholesterol content. For 
this analysis, the blood spot (5 Ul) was sonicated with CHCl3-MeOH reagent 
containing a fixed amount (5.0 Pg) of labelled cholesterol. As previously 
an aliquot of the extract was introduced to the MS for the free cholesterol 
determination whilst the remaining portion was hydrolyzed with Na/MeOH 
solution (50 yl) and then evaporated and redissolved in hexane. The re-
sults of five such separate analyses are summarized in Table 19. 
We further checked the possibility of analyzing blood cholesterol 
esters by this method. To do this we examined the mass spectra of 
cholesteryl stearate and cholestryl palmitate and found that, unlike the 
free cholesterol, the cholesterol esters of biological interest volatized 
at much higher probe temperature, e.g., 250-300°C. At these probe tem-
peratures, the mass spectra of the cholesterol esters primarily showed 
the "dehydrated ion peak" of cholesterol (m/e 369) and the protonated 
(MH)+ peak of the corresponding fatty acid, e.g., Cie-.o ^^^^ ^^^ 
C^g.Q (m/e 285). These results are in agreement with the recently 
published work of Murata et al.(79)^ 
Table 18. Comparison of serum analysis for total cholesterol, 
as obtained by mass spectrometry and the enzymatic 
method 
Total Cholesterol (mg %) Serum 
Mass Spectrometry Enzyme Method^ 
1 219.2 222.3 221.8 
2 238.5 236.1 242.1 
3 240.5 238.6 234.7 
4 100.1 101.7 99.9 
5 224.1 226.5 227.8 
6 243.6 246.3 252.5 
^Calbiochem Enzymatic Cholesterol S .V.R. Doc No. L06011, August 1, 1975 
Table 19. Blood analysis for free and total cholesterol 
by mass spectrometry. Blood spot (S.L., 5 Ul) 
Free Cholesterol (mg %) Total Cholesterol (mg %) 
75.62^ 196.75^ 
77.20 195.50 
76.11 194.06 
76.96 195.71 
77.08 196.12 
Mean: 76.59 196.63 
S.D. 0.64 1.08 
^Average of 
150°C 
five scans for each analysis. Probe t° = 
For calibration purposes, a fixed amount (5 Ug) of labelled cholesteryl 
palmitate or cholesteryl stearate which was prepared by a published 
method(80) ^as added to varying amounts of a reference unlabelled choles-
terol ester solution and the peak height ratio at m/e 369 and m/e 373 were 
monitored. The calibration experiments were also carried out by using 
whole blood (Fig.23) to which additional reference cholesteryl palmitate 
or stearate ester had been added so that the 5 yl blood spot samples con-
tain a concentration range of 0-9 Ug of cholesterol esters. For the 
analysis, the blood spot was extracted with CHCI3 - MeOH reagent contain-
ing a fixed amount of labelled cholesteryl palmitate. The mass spectra 
were then recorded at probe temperature of 270 + 10°C and the concentra-
tion of the cholesterol esters in the blood was calculated. The effect of 
the presence of free cholesterol on the assay was checked by adding 
cholesterol (10 ]ig) to the blood. The results of these experiments showed 
that our procedure only measure esterified cholesterol. 
The method was then used to determine esterified cholesterol in 
normal blood. For this a 5 yl blood spot disc was used and the total 
cholesterol and other lipids were extracted with CHCl^ - MeOH containing 
the labelled cholesteryl palmitate (5.0 yg) . Table 20 summarizes the 
results obtained from the mass spectrometric analysis of cholesterol after 
alkaline hydrolysis of blood and by direct mass spectrometric blood 
analysis. 
The direct estimation of blood esterified cholesterol also allows 
us to measure the relative abundance of the physiologically important 
cholesterol esters commonly found in blood; namely, cholesterol esters of 
^16:0-^20:4 f^tty acids. 
When individual cholesterol esters, e.g., cholesteryl palmitate or 
cholesteryl stearate, are analyzed by MS at probe temperature of 270°C 
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Fig. 23. Calibration curve for the quantitative determination of cho-
lesteryl palmitate ester in blood. Blood was supplemented 
with cholesteryl palmitate to produce concentration of 0 to 
9.0 g per 5 1 dried blood spot. A fixed amount (ca. 5 g) 
of deuterium labelled cholesteryl palmitate was used for 
each analysis. The dehydrated ion peaks of cholesterol 
esters at m./e 369 and of deuterated cholesteryl palmitate 
at m/e 373 were used for the determination of the peak 
height ratio. 
Table 20. Comparison of blood analysis for esterified cholesterol, 
as obtained by mass spectrometry with or without alka-
line hydrolysis 
Blood Sample 
Esterified Cholesterol (mg %) 
(5 yi) Hydrolysis Method^ Direct Mass Spectrometry^ 
1 90.98 92.05 91.75 92.52 
2 131.61 132.72 130.45 133.42 
3 80.18 79.59 79.32 81.06 
4 120.86 120.17 119.04 120.21 
5 140.09 141.37 142.18 143.52 
^Deuterium labelled cholesterol (ca. 5 yg) was used as internal standard 
for the analysis of free and total cholesterol after alkaline hydrolysis. 
The solid probe temperature was held at 150 + 10°C. The figures quoted 
are an average of five spectral scans. Esterified cholesterol values 
were calculated from the total cholesterol value minus the free choles-
terol . 
^Deuterium labelled cholesteryl palmitate (ca. 5 yg) was used as internal 
standard for the analysis of esterified cholesterol (esters). The solid 
probe temperature was held at 270 + 10°C. The figures quoted are an 
average of five spectral scans. 
the peak height ratio of the dehydrated cholesterol ion (m/e 369) and the 
corresponding fatty acid protonated ions (m/e 257 for C^^^.Q and m/e 285 for 
^18:0^ can be determined. When a mixture of the above esters is analyzed 
under the same conditions, the corresponding fatty acid peaks can also be 
recorded and the peak height ratios can be calculated (Table 21). The 
data show that the method can also be used to determine the relative 
abundance of the fatty acid components derived from them (Table 22). Our 
method thus allows us to estimate both the level and composition of 
cholesterol esters in blood. 
Since estriol levels reflect foetal well-being, particularly during 
the late stages of pregnancy, there is a clinical need for a rapid analysis. 
We have also examined the applicability of the mass spectrometric technique 
for this purpose. 
A sufficient amount of estriol for our analysis could be extracted 
with diethyl ether from only 100 yl of, acid hydrolyzed, pregnancy urine 
and the mass spectrum of estriol showed peaks at m/e 289 (50% intensity) 
and m/e 271 (50% intensity) which corresponds to the protonated molecular 
ion (MH"^) and the dehydrated ion (MH-H^D)"^, respectively (Table 23). 
By using a fixed amount (4 yg) of estriol-D2 (m/e 291) which was 
prepared by a published method(81), a calibration curve for estriol 
(m/e 289) was determined for a 0-9 Pg concentration range. Graphic 
analysis of the data confirmed the linearity of the assay (Fig. 2 4 ) . The 
technique was then employed with hydrolyzed urine specimens by spiking 
with a solution of the appropriate estriol-D2 as internal standard. The 
mass spectral results were compared with those obtained by a fluorescence 
autoanalyzer method (Table 24). The data indicate that mass spectral 
results are consistently lower than those obtained by the fluorimetric 
method<^2). This is due to the fact that the classical method measures 
Table 21. Mass spectral data on cholesterol esters. 
Probe tO = 270°C. 
(Cholesterol/Fatty Acid) Ratio Fatty Acid Ratio^ 
Choi, (m/e 369) Choi, (m/e 369) Cl6:0 (m/e 257) 
^16:0 (m/e 257) Cl8:0 (m/e 285) ^16:0 (m/e 285) 
0.93 0.94 1.18 
0.94 0.97 1.19 
1.06 0.90 1.22 
1.00 0.88 1.09 
1.00 0.87 0.92 
Mean: 0.99 0.91 1.12 
S.D. 0.05 0.04 0.11 
^Cholesteryl palmitate: cholesteryl stearate (1:1 w/v) 
Table 22. Mass spectral data on fatty acids derived from cholesterol 
esters in blood. Solid probe temperature 270 + 10°C. 
Fatty Acid (MH)"̂  
m/ e 
Blood Sample (5 yi) 
(A) (B) (G) (D) (E) (F) 
^16:0 257 100 100 100 100 100 100 
^16:1 255 29 27 28 26 24 30 
^18:0 285 45 62 58 66 44 48 
^18:1 283 55 69 70 59 44 50 
^18:2 281 23 23 18 33 16 24 
^18:3 279 16 23 15 17 12 19 
^20:0 313 55 39 33 66 20 15 
^20:1 311 13 15 16 20 9 10 
^20:4 305 - - - - - -
Table 23. Isobutane CI-MS analysis of estrogens 
(MH)+ (MH - H20)"^ 
Estrogen MW , Ion Peak Intensity 
m/e m/e 
Estrone 270 271 253 100 : 1 
Estradiol 272 273 255 50 : 50 
Estriol 288 289 271 50 : 50 
0 2 4 6 8 
ESTRIOL CONCENTRATION, ^g 
Fig. 24. Calibration curve obtained from a mixture of estriol 
and estriol-D2. A fixed amount (4 yg) of estriol-D2 
was used for each analysis. 
Table 24. Analysis of estriol (mg/liter) in pregnancy urine 
by CI-MS and fluorimetry 
Urine Mass Spectrometry^ Fluorimetry 
1 9.12 + 0.27 10.34 
2 10.89 + 0.26 11.42 
3 8.67 + 0.26 9.08 
4 10.75 + 0.29 11.21 
5 12.65 + 0.33 13.23 
6 9.27 + 0.26 10.59 
7 13.53 + 0.39 14.78 
8 8.79 + 0.25 9.68 
^ean + standard error of mean (from three determinations) 
the total estrogens, e.g., estrone, estradiol and estriol, etc. 
A recovery study was therefore carried out by adding increasing 
amounts of estriol to the hydrolyzed urine sample and measuring the in-
creases in peak height ratio due to these additions as compared to the 
response of samples with zero addition. Recovery values for estriol ranged 
from 94-103%. 
The quantitative analysis of protein hydrolysates is of considerable 
importance to research in many of the biosciences. We therefore have 
investigated the applicability of mass spectrometry in this field by 
analyzing a number of pure peptide hydrolysates. 
For the analysis, each peptide hydrolysate was divided into two por-
tions, one of which was analyzed by ion-exchange chromatography and the 
other by direct mass spectrometry. Table 25 shows the results expressed 
as moles of amino acid present in each peptide as obtained by the two 
methods. The good agreement between the two analyses suggests that the 
new technique, which only takes 15 minutes as compared to 3-4 hours for 
ion-exchange chromatography, may have some value in this field. 
It seemed pretty obvious that the new technique will also be quite 
useful for some non-clinical problems. It so happened that this department 
has been interested in the use of stable isotopically labelled substrates 
for the diagnosis and study of genetic defects. In these experiments, a 
stable isotopically labelled substrate is administered orally to the 
patient and the appearance and level of deuterated substrate and its 
metabolites in the body fluids are followed in a time course experiment. 
We have used the new amino acid analysis to determine the ratio of labelled 
to unlabelled serum and urinary amino acids. For these analyses, serum or 
urine was treated as described previously and the molecular ions of the 
corresponding N-acetyl amino acid methyl esters were monitored and recorded. 
Table 25. Comparison of ion-exchange results and values determined 
in this study for amino acids derived from peptide hydrol-
ysates 
Peptide 
Hydrolysate 
Amino Acid Residue (mole) 
Mass Spectrometry^ Ion-Exchange Chromatography 
A. Asp 1.1 1.1 
Phe 1.0 1.0 
B. Gly 1.1 1.0 
Met 1.0 1.0 
Phe 1.1 1.1 
C. Asp 1.0 1.0 
Gly 0.98 0.95 
Met 1.04 0.88 
Phe 0.95 0.98 
D. Met 1.0 1.0 
Asp 1.1 1.3 
Val 1.3 1.2 
Glu 1.0 1.3 
Leu 1.2 1.2 
Phe 1.0 1.2 
a 
Average of two analyses. 50 yl hydrolysate equivalent to 2-8 yg of 
peptide was spiked with 12.5 n mole of the correspondingly labelled 
amino acid standards. 
In this way, the deuterium content of the serum amino acids could be 
determined by examining the relative peak heights of the labelled to the 
unlabelled protonated molecular ion (MH)"̂  without the use of an internal 
standard. The percent of deuteration could then be calculated from (Peak 
Height of Labelled) x 100. 
To determine the amino acid concentration of both the labelled and the 
unlabelled species present in the sample, the addition of the same amino 
acid but differently labelled is required. For example, a patient suffer-
ing from a defect in valine metabolism, namely methylmalonic aciduria, was 
fed deuterated valine Dy (50 mg per kg body weight) and samples of blood 
and urine were taken at hourly intervals. The serum and urinary labelled 
and unlabelled valine concentrations(Tables 26 and 27) were determined by 
the CI-MS method using valine-D^ as the internal standard (Scheme A). 
Scheme A - Addition of valine-D^ in direct analysis of D^ and Dy contents 
5z I 
»7! 
D, 
VALINE 
D, 
Mg % Val-D_ = 
(-^f^) sample (Wt. of DQ) calib. 
.. X 100 
calib. 
x 
Sample Vol 
Mg % Val-Dy = (D^/DQ) X Mg % DQ, where 
d; = (D_ - f,); and f. = D, contribution / / b b D 
D-
D % X 100 
If a differently labelled amino acid is not available for use as an 
internal standard, it is still possible to determine the concentration of 
the labelled and unlabelled amino acid. In this approach the percent 
labelled species is determined first and then the concentration of the 
labelled and unlabelled amino acid is determined by the addition of a 
Table 26. Serum valine (DQ) and Valine (DY) levels^ in methylmalonic 
aciduria patient (P.B.) after valine (DY) load 
Time 
Serum Valine Levels (mg %) 
% D 
Do 
(m/e 174) 
D7 
(m/e 181) 
1 1/2 1.77 2.48 58 
2 5.53 0.61 19 
4 2.48 0.27 10 
8 2.67 0.18 7 
25 1.85 0.15 8 
49 1.74 0.16 8 
^50 yl serum, ion-exchange chromatographically cleaned. Valine-D^ 
(m/e 180) 12.5 n mole used as internal standard. Average of two 
determinations. 
Table 27. Urine valine (DQ) and valine (DY) levels^ in methylmalonic 
aciduria patient (P.B.) during valine (DY) loading test 
Urine Valine Levels (mg %) 
Time 
(hr) Do 
(m/e 174) 
D7 
(m/e 181) 
% D 
0 1.03 - -
1 1/2 1.77 0.14 7 
3 3/4 1.11 2.99 73 
4 1/2 0.48 0.41 46 
7 0.93 0.82 47 
8 3/4 0.95 0.31 25 
22 0.30 0.12 29 
^100 \xl urine, ion-exchange chromatographically cleaned. Valine-D^ 
(m/e 180) 12.5 n mole used as internal standard. Average of two 
determinations. 
known amount of unlabelled amino acid to the sample. For example, two 
patients suffering from a defect in tyrosine metabolism were fed tyrosine-D2 
(50 mg/kg body wt.) and serum samples were taken at hourly intervals. The 
ratio of labelled to unlabelled tyrosine in the serum was determined in the 
first experiment (Table 28). In the second experiment, 12.5 n moles of 
unlabelled tyrosine (D ) was then added to each sample and the concentration 
o 
of both labelled and unlabelled species (Table 29) was determined by 
S cheme B. 
It should be noted that the determination of serum or urine tyrosine-
D^ by classical GC-MS was not possible since the derivatization of tyrosine 
for GC requires acid catalyzed esterification which led to a partial loss 
of deuterium and our di-acetyl tyrosine derivative methyl ester was not 
sufficiently volatile for gas chromatography. 
Scheme B - Addition of unlabelled amino acid in the second experiment 
Y 
X 
o 
T+ D 
o 
1st Expt. 
Where X^ = under normalization, and 
R = X_/X^, and Ry = Y^/Y^ 
2nd Expt. 
x o' 2 
R Wt. of D used 
X .. o X 100 
Mg % of unlabelled amino acid (X ) - - - x 
^ - ^ x Sample Vol. 
Mg % of labelled amino acid (X2) = Mg % X^/R^ 
Table 28. Serum tyrosine (% deuterated) in tyrosinemia patient 
(S.T.) during tyrosine-D2 loading test 
Deuterated Tyrosine^ 
(hr) (%) 
0 0 
2 31 
6 28 
24 18 
^50 yl serum, deproteinized, derivatized and analyzed by CI-MS. Average 
of two determinations. 
Table 29. Serum tyrosine-DQ and tyrosine-D2 levels in tyrosinemia 
patient (S.T.) during tyrosine-D2 loading test^ 
Time (hr) Tyrosine-DQ (mg %) 
(m/e 280) 
Tyrosine-D2 (mg %) 
(m/e 282) 
0 2.21 0 
2 8.64 3.82 
6 6.25 2.39 
24 22.87 4.87 
^50 yl serum. Tyrosine-DQ (m/e 280) 12.5 n mole was used as internal 
standard. Average of two determinations. 
EXPERIMENTAL 
I. Quantitative Analysis of Amino Acids 
Reagents were obtained as follows: Acetic anhydride from B.D.H. 
(Poole, England), methyl alcohol (anhydrous) from Mallinckrodt Chemical 
Works (St. Louis, USA), and trimethylphenylammonium hydroxide (TMPH, 0.1 M 
in methanol), trifluroacetic acid anhydride from Eastman Kodak Co. 
(Rochester, USA). Pivaldehyde (2,2-dimethyl propanal) was supplied by 
K and K Laboratories, Inc. (New York, USA). Tetramethylammonium hydroxide 
(TMAH, 24% in methanol), tetraethylammonium hydroxide (TEAR, 24% in 
methanol), acetylacetone, ethylacetoacetate, and molecular sieve (3 A) 
were obtained from Matheson Coleman and Bell (New Jersey, USA). Hydro-
chloric acid in n-butanol (3 N) was supplied by Regis Chemical Co. (Morton 
Grove, USA). Protein amino acids were obtained from Nutritional Bio-
chemicals Corp. (Cleveland, USA) and the stable istopically labelled amino 
acid standards; aspartic acid-^%, glutamic acid-^^N, glycine-2, 2-D2, 
tyrosine-3,5-D2, valine-D5 and methionine-D3 which had a minimum iso-
topic purity of 98% were obtained from Merk, Sharp and Dohme (Quebec, 
Canada). Leucine-^%, 99% was provided by Stohler Isotope Chemicals 
(California, USA). The deuterated phenylalanine was prepared according 
to the method of Milstein and Kaufman(83). Alanine-D3 was synthesized 
from methyl iodide-D3 and diethyl acetamidomalonate according to Snyder's 
method(8^). 
A. Derivatization of Amino Acid 
Solutions of a single amino acid or amino acid mixtures (10-100 n 
mole, 2.5 mM in 0.1 N HCl) were transferred to a micro-reaction vial 
(0.5 ml capacity) and the appropriate amino acid (25-50 n mole, 2.5 mM in 
0.1 N HCl) or amino acid mixture internal standard, labelled with either 
deuterium (D) or nitrogen-15 (^^N) was added. The solution was then 
Evaporateci to dryness at 80°C, under a stream of nitrogen using a heating 
block apparatus (85). and followed by derivatization: 
(a) Preparation of Neopentylidine Amino Acid Methyl Ester Via Pyrol-
ysis of Neopentylidine Amino Acid Tetramethy1ammoniurn Salt 
The dry amino acid was redissolved in TMAH or TMPH (10 yl, 0.1 M in 
methanol) and pivaldehyde (10 Ul) in the presence of molecular sieve 3A 
(1 stick). After a reaction period at room temperature of 15 min., the 
molecular sieve was removed and the solutions of amino acid ammonium salts 
were transferred to the solid probe tip of the mass spectrometer and 
evaporated under reduced pressure. The probe tip was then heated to about 
80°C in the ion source region of the mass spectrometer or until a steady 
evolution of PhN(CH3)2 at m/e 120 and 121 or N(CH3)3 at m/e 59 and 60 was 
observed on the oscilloscope display of the mass spectrometer. After the 
pyrolysis conversion of N-protected amino acid ammonium salt into N-
protected amino acid methyl ester was complete (10-30 min.) the probe 
temperature was increased gradually until the amino acid spectrum ap-
peared on the oscilloscope display. The msL&s njjtftbiw: of neopentylidine 
amino acid methyl esters of some selected amino acids are summarized in 
Table 30 by both EI and CI mass spectrometry. 
(b) Preparation of Acetylacetonyl Amino Acid Methyl Ester Via Pyrol-
ysis of Acetylacetonyl Amino Acid Tetramethylammonium Salt 
The dry amino acid was redissolved in TMAH or TMPH (10 yl, 0.1 M in 
methanol) in the presence of acetylacetone (10 yl) and molecular sieve 3A 
(1 stick). After 6 h at room temperature, the molecular sieve was re-
moved and the solutions of amino acid ammonium salts were transferred to 
the solid probe tip of the mass spectrometer and evaporated under reduced 
pressure. The probe tip was then heated to about 80°C in the ion source 
Table 30. Mass number of neopentylidene amino acid methyl esters 
by EI and CI mass spectrometry 
Amino Acid 
Mass Number, m/ e 
EI (M - C00CH3)+ CI (MH)+ 
Gly 98 150 
Ala 112 172 
Val 140 200 
Leu 154 214 
Met 172 232 
Phe 188 248 
region of the mass spectrometer or until a steady evolution of PhN(CH3)2 
at m/e 120 and 121 or N(CH3)3 at m/e 59 and 60 was observed on the oscil-
loscope display of the mass spectrometer. After the pyrolysis conversion 
of N-protected amino acid ammonium salt into N-protected amino acid methyl 
ester was complete (10-30 min.) the probe temperature was increased 
gradually until the amino acid spectrum appeared on the oscilloscope dis-
«̂ H"̂  iotas 
play. The loaAS nusaeir of acetylacetonyl amino acid methyl esters of some 
selected amino acids are summarized in Table 31 by both EI and CI mass 
spectrometry. 
(c) Ethylacetoacetyl Amino Acid Methyl Ester Via Pyrolysis of 
Ethylacetoacetyl Amino Acid Tetramethylammonium Salt 
The dry amino acid was redissolved in TMAH or TMPH (10 yl, 0.1 M in 
methanol) in the presence of ethylacetoacetate (10 pl) and molecular 
sieve 3A (1 stick). After a reaction period of 15 min. reflux, the 
molecular sieve was removed and the solutions of amino acid ammonium salts 
were transferred to the solid probe tip of the mass spectrometer and 
evaporated under reduced pressure. The probe tip was then heated to 
about 80°C in the ion source region of the mass spectrometer or until a 
steady evolution of PhN(CH3)2 at m/e 120 and 121 or N(CH3)3 at m/e 59 and 
60 was observed on the oscilloscope display of the mass spectrometer. 
After the pyrolysis conversion of N-protected amino acid ammonium salt 
into N-protected amino acid methyl ester was complete (10-30 min.) the 
probe temperature was increased gradually until the amino acid spectrum 
appeared on the oscilloscope display. The mass number of ethylacetoacetyl 
amino acid methyl esters of some selected amino acids are summarized in 
Table 32 by both EI and CI mass spectrometry. 
Table 31. Mass number of acetylacetonyl amino acid methyl esters 
by EI and CI Mass Spectrometry 
Amino Acid Mass Number, m/e 
EI (M - C00CH3)+ CI (MH)+ 
Gly 112 172 
Ala 126 186 
Val 154 214 
Leu 168 228 
Met 186 246 
Phe 202 262 
Table 32. Mass number of ethylacetoacetyl amino acid methyl esters 
by EI and CI mass spectrometry 
Amino Acid 
Mass Number, e/e 
EI (M - C00CH3)+ CI (MH)+ 
Gly 142 202 
Ala 156 216 
Val 184 244 
Leu 198 258 
Met 216 276 
Phe 232 292 
(d) Preparation of N-acetyl Amino Acid Methyl (or Ethyl) Ester Via 
Pyrolysis of Acetyl Amino Acid Tetramethyl or Tetraethyl Ammonium Salt 
The dry amino acid was redissolved in TMAH (10 yl, 0.1 M methanol), 
TMAH (10 yl, 0.1 M ethanol), TEAH (10 yl, 0.1 M methanol), or TEAH (10 yl, 
0.1 M ethanol) in the presence of acetic anhydride (10 yl) and molecular 
sieve 3A (1 stick). After 2 hours at room temperature, the molecular 
sieve was removed and the solutions of amino acid ammonium salts were 
transferred to the solid probe tip of the mass spectrometer and evaporated 
under reduced pressure. The probe tip was then heated to about SO'̂ C in 
the ion source region of the mass spectrometer or until a steady evolution 
of PhN(CH3)2 at m/e 120 and 121 or N(CH3)3 at m/e 59 and 60 was observed 
on the oscilloscope display of the mass spectrometer. After the pyrolysis 
conversion of N-protected amino acid ammonium salt into N-protected amino 
acid methyl ester was complete (10-30 min.) the probe temperature was in-
creased gradually until the amino acid spectrum appeared on the oscil-
loscope display. The mass number of N-acetyl amino acid methyl (or 
ethyl) esters of some selected amino acids are summarized in Table 33 by 
both EI and CI mass spectrometry. 
(e) Preparation of N-acetyl Amino Acid Methyl (or Ethyl) Ester 
using Acetic Anhydride - Methanol (or Ethanol) 
The dry amino acid was redissolved in a mixture of acetic anhydride 
(20 yl) and methanol or ethanol (100 yl) in the presence of molecular 
sieve 3A (1 stick). After 5 min. to 30 min. at 100°C, the molecular 
sieve was removed and the solutions were transferred to the solid probe 
tip of the mass spectrometer and evaporated under reduced pressure. The 
probe tip was then heated gradually (80-200°C) until the amino acid 
spectrum appeared on the oscilloscope display. The CI mass spectra of 
Table 33. Mass number of N-acetyl amino acid derivatives of methyl 
and ethyl esters by EI and CI mass spectrometry 
Amino acid 
Methyl Ester (m/e) Ethyl Ester (m/e) 
EI (M-C00CH3)+ CI (MH)+ EI (M-C00CH3)+ CI (MH)+ 
Gly 72 132 86 146 
Ala 86 146 100 160 
Val 114 174 128 188 
Leu 128 188 142 202 
Met 146 206 160 220 
Phe 162 222 176 236 
N-acetyl amino acid methyl (or ethyl) esters were recorded and the mass 
number of N-acetyl amino acid derivatives was determined (Table 33). 
(f) Preparation of N-trifluoroacetyl Amino Acid n-Butyl Ester(Q^) 
The dry amino acid was sonicated with 3N HCl/n-butanol (150 yl) and 
heated for 15 min. at 100°C, and the solution was then evaporated to 
dryness with nitrogen. A solution of trifluoroacetic anhydride-dichloro-
methane (1:3 v/v, 100 ul) was then added into the reaction vial and the 
vial was tightly capped, sonicated (1 min.) and heated at 150°C for 5 min. 
An aliquot of the solution (5 Ul) was used for gas chromatographic 
analysis and aliquots of 10-15 ]il were transferred to the solid probe 
tip of the mass spectrometer and evaporated under reduced pressure. The 
probe tip was then heated gradually (80-200°C) until the amino acid 
spectrum appeared on the oscilloscope display. The mass number of N-
trifluoroacetyl amino acid n-butyl esters of some selected amino acids 
are summarized in Table 34. For gas chromatography, an EGA column (0.325% 
on 80/100 mesh a.w. HT Chromosorb C, 6 in x 1/2 in I.D., U-glass) was used 
for the separation of the N-acetyl amino acid derivatives. The gas 
chromatograph used was a Tractor MT 220 model equipped with a Coulson 
nitrogen detector. The GLC instrumental setting and parameters are shown 
in Table 35. 
B. Preparation of Plasma Amino Acid 
Plasma (50 yl) was transferred to a centrifuge tube and a standard 
solution of labelled amino acid (12.5 n mole, 5 yl of 2.5 mM solution in 
0.1 N HCl) was added, followed by absolute alcohol (200 yl) . The solu-
tion was shaken and then centrifuged (5 min., 2600 rev/min.). The 
supernatant was transferred to a reaction vial and evaporated to dryness 
under a stream of dry nitrogen. The dry residue was then redissolved in 
mixture of acetic anhydride (20 yl) and methanol (100 yl) in the presence 
Table 34. Mass number of N-trifluoroacetyl amino acid n-butyl ester 
by CI mass spectrometry 
Mass Number (m/e) 
Amino Acid — 
(MH)+ 
Gly 228 
Ala 242 
Val 270 
Leu 284 
Met 302 
Phe 318 
Table 35. Gas Chromatograph conditions for the separation of N-
trifluoroacetyl amino acid n-butyl ester using Coulson 
Electrolytic Conductivity Detector 
Column 0.35 w/w7o EGA on 80/100 Mesh A. W, H. T. Chromosorb G.^ 
Helium flow ml/min 
Carrier 
Pyrolyzer 
Hydrogen flow, ml/min 
Pyrolyzer (Detector) 
Pyrolyzer temperature, °C 
Initial temperature, °C 
EGA 
Programmed temperature, °C/min 
Final temperature, °C 
Inlet temperature, °C 
Chart speed, in./min 
60 
10 
50 
820 
90 
5 
235 
210 
0.5 
^EGA = Ethylene Glycol Adipate 
H. T. = Heat treated at 550 C for 16 hours 
of molecular sieve 3A (1 stick). After 5 min. at 100°C heating period, an 
aliquot of 10 ]il solution was transferred to a probe tip sample holder, 
evaporated under vacuum, and admitted through a direct insertion probe 
for MS analysis. The probe tip was then heated slowly in the ion source 
region of the mass spectrometer (80-180°C) until the amino acid spectrum 
appeared on the oscilloscope display. The mass spectrum of N-acetyl amino 
acid methyl esters was then recorded with a background spectrum being 
recorded at 50°C. The mass number of the N-acetyl amino acid methyl 
ester and their corresponding internal standard used in the study of 
ratio determination by CI-MS are summarized in Table 36. The peak height 
ratio of unlabelled to labelled amino acid was thus calculated. 
C. Preparation of Amino Acids from 5 yl Dried Blood Sample 
The whole blood (5 Ul, heparinized) was spotted on filter paper 
(Guthrie blood test paper) and dried at 100°C for 10 min. and was then 
stored in the desiccator (anhydrous CaSO^, indicating desiccant) before 
use. The dried blood spot (5 yl) was punched out (with 4 mm diameter 
cork puncher) and placed in a reaction vial, aqueous ethanol (200 yl, 80% 
v/v) and labelled amino acid (12.5 n mole, 5 yl of 2.5 mM solution in 
0.1 N HCl) were added. The vial was capped and the contents ultra-
sonically mixed* for 5 min. The filter paper disc, which retains the 
denatured protein, was removed with tweezers and the solution was evapo-
rated to dryness with nitrogen at 80°C. The residue was then redissolved 
in a mixture of acetic anhydride (10 yl) and methanol (50 yl) in the 
presence of molecular sieve 3A (1 stick). After 5 min. at 100°C heating 
period, an aliquot of 10 yl was transferred into a probe tip sample 
holder, evaporated under vacuum, and admitted through a direct insertion 
probe for MS analysis. The probe tip was then heated slowly in the ion 
Table 36. Mass number of N-acetyl amino acid methyl esters used 
for ratio determination by CI mass spectrometry 
Amino Derivative Type Mass Number (MH+,m/e) Internal Standard 
Acetyl Methyl Unlabelled Labelled (D or N-15) 
Gly Mono- Mono- 132 134 Gly - D2 
Ala M I I 146 149 Ala - D3 
Val I I 174 180 Val - ̂ 6 
Leu & lie M I I 188 189 Leu -
Asp I t Di- 204 205 Asp -
Met I I Mono- 206 209 Met -
Glu M Di- 218 219 Glu - 1 % 
Phe I I Mono- 222 227 Phe - % 
Lys Di- M 245 246 Lys -
Tyr n M 280 282 Tyr - ̂ 2 
source region of the mass spectrometer until the amino acid spectrum 
appeared on the oscilloscope display. The mass spectrum of N-acetyl amino 
acid methyl esters \̂ as then recorded at 80 - 180°C with a background 
spectrum being recorded at 50°C. The mass number (Table 1) of the N-
acetyl amino acid derivatives and their corresponding internal standard 
were measured and the peak height ratio of the unlabelled to labelled amino 
acid was determined. The effect of the drying process on blood amino 
acid content was determined by the following experiments: Whole blood was 
supplemented with glycine, alanine and phenylalanine to produce concen-
tration of 0 (control), 5 and 10 n mole per 5 yl dried blood spot. A 
fixed amount (10 n mole) of labelled internal standards, e.g., glycine-D2, 
alanine-D3 and phenylalanine-D^ was then used for each analysis. The peak 
height ratios for glycine (m/e 132 / 134), alanine (m/e 146 / 149) and 
phenylalanine (m/e 222 / 227) were determined from the mass spectra. The 
analytical results showed that the drying procedure (100°C/10 min) did 
not change the blood amino acid content. 
* CAUTIONS : Criteria for good sonication of samples: (1) Reaction 
vial should be thin-walled type (1 mm thick) and the inside diameter 
(available space) should be at least 6 mm; (2) The sample reagent con-
taining filter paper disc should be submerged under the water surface 
level of the ultrasonic unit during mixing and extraction; and (3) A good 
visible agitation both inside and outside the reaction vial is essential. 
D. Preparation of Amino Acids from Dried Blood Spotted on Guthrie Test 
Paper 
The whole blood spot (ca. 10 mm - 15 mm) was punched out discs (4 mm 
dia. with 4 mm stainless cork puncher) and each of them was placed in a 
reaction vial, aqueous ethanol (200 yl, 80% v/v) and the corresponding 
labelled amino acid (12.5 n mole, 5 yi of 2.5 mM solution in 0.1 N HCl) 
it» , 
were added. The vial was capped and the contents ultraso^cjfally mixed for 
5 min. The filter paper disc, which retains the denatured protein, was 
removed with tweezers and the solution was evaporated to dryness with 
nitrogen at 80°C. The residue was then redissolved in a mixture of 
acetic anhydride (10 Ul) and methanol (50 yl) in the presence of molecular 
sieve 3 A (1 stick). After 5 min. at 100°C heating period, an aliquot of 
10 yl was transferred into a probe tip sample holder, evaporated under 
vacuum, and admitted through a direct insertion probe for MS analysis. 
The probe tip was then heated slowly in the ion source region of the mass 
spectrometer until the amino acid spectrum appeared on the oscilloscope 
display. The mass spectrum of N-acetyl amino acid methyl esters was then 
recorded at 80 - 180°C with a background spectrum being recorded at 50°C. 
The peak height of the unlabelled and the labelled amino acids were 
measured and the peak height ratio was calculated for glycine (m/e 132 
vs. m/e 134), alanine (m/e 146 vs. m/e 149), valine (m/e 174 vs. m/e 180) 
and phenylalanine (m/e 222 vs. m/e 227). The results of spectral 
analysis showed that no detectable blood amino acids separation occurred 
within the 10 to 15 mm spots. For quantitative analysis, the amount 
(volume) of blood in 4 mm disc should be determined. For this purpose, 
the following experiments were carried out. 
E. Calibration of 4 mm Dried Blood Disc from Guthrie Test Paper Using 
4 mm Stainless Puncher 
For the determination of blood volume in 4 mm discs punched off with 
4 mm stainless cork puncher, three calibration experiments on the blood 
spot samples were conducted: (1) the calibration of known size (4 ram) 
and known volume (5 yl) blood spots containing 2 - 20 mg7o phenylalanine; 
(2) the calibration of known size (10-15 mm) but unknown volume blood 
spots containing 4 - 1 0 mgJo phenylalanine; and (3) the calibration of 
known blood phenylalanine concentration (10 mg7o) from the blood spotted 
on Guthrie Test paper of 5 yl (equivalent to the size of 4 ram) or of 10 -
15 mm (close to the circled ring as instruction given on the Guthrie Test 
paper) (Fig. 25). 
In the first experiment, each 4 ram blood spot containing 5 yl blood 
run in duplicate was extracted with 200 yl ethanol (80%) containing 
12.5 n mole of Phe-D^ (5 yl of 2.5 raM solution in 0.1 N HCl), and the 
extract was dried with nitrogen, redissolved in a mixture of acetic 
anhydride-methanol (10 yl + 50 yl) and heated at 100°C for 5 rain. The 
solution (10 yl) was transferred into a probe tip sample holder, evapo-
rated under vacuum and admitted through a direct insertion probe for MS 
analysis. The results of this experiments showed a linear concentration 
curve for blood phenylalanine plotted as peak height ratio (m/e 222 for 
phenylalanine and m/e 227 for phenylalanine-D5) on Y-axis vs. a range of 
phenylalanine level (2-20 mgX) on X-axis. In the second experiments, the 
same 4 mm puncher was used to punch out discs from the large blood spots 
(10-15 mm) containing 4 mg7o, 6 mg7o, 8 mg7o and 10 rag7o phenylalanine on 
Guthrie Test paper (run in duplicate). The disc taken within the large 
blood spots were then processed individually as previously described for 
MS analysis. Again, a linear curve for blood phenylalanine concentration 
was obtained when the average peak height ratio of unlabelled to labelled 
phenylalanine (ra/e 222 vs. 227) was plotted against phenylalanine 
concentration. In the third experiments, 4 mm blood discs from 5 yl 
blood and 4 mm blood discs from 10 - 15 mm blood spots were individually 
analyzed for the peak height ratio when a fixed amount of Phe-D^ (12.5 n 
mole, 5 yl of 2.5 mM solution in 0.1 N HCl) was used for each analysis 
( A ) 
4 mm punch 
Blood spot 
o o 
o o 
( B ) 
4 mm punch 
Blood spot 
Co) 
Fig. 25. Calibration of 4 mm (dia.) dried blood disc sample 
from Guthrie Test Paper using (A) 5 yl blood spot, 
and (B) 10 - 15 mm size blood spot. 
in total of eight determinations. The MS procedure was the same of the 
two previous experiments and the spectral data, e.g., peak height ratio 
of phenylalanine (m/e 222 vs. 227) was averaged from four sample runs for 
each group, e.g., 4 mm and 10 - 15 mm blood samples. The results of these 
experiments showed that the 4 mm disc, punched out with a 4 mm stainless 
puncher from the 10 - 15 mm blood spots of Guthrie Test paper, contains 
a blood volume of 5.5 Ul + 0.2. 
F. Mass Spectrometry of Amino Acids 
The CI mass spectra were recorded on a Dupont 21-491 B mass spectro-
meter modified for operation in the chemical ionization (C.I.) mode. The 
reagent gas used was isobutane at pressure between 0.5 - 1.0 Torr. The 
source temperature was maintained at 200°C and the probe temperature was 
varied from ambient to 200°C. The energy of the electron beam was 70 eV. 
The block voltage was 1400 V d.c. and the repeller plates were maintained 
at the block voltage. Mass spectra of amino acid derivatives were re-
corded from 80 - 200°C with a background spectrum being recorded at 50°C. 
The spectra shown in the plots were reconstructed from the combined 
spectra obtained at different solid probe temperatures after subtracting 
the background spectrum. The ^^c isotope ratio and the CI peaks due to 
the isobutane have been left out of the reconstructed plots to allow 
simpler presentation of the results. The mass number (MH+) of the 
volatile amino acid derivatives and their corresponding internal standard 
used for ratio determination by CI-MS are presented in Tables previously. 
The concentrations of the individual amino acids were determined by 
comparing the average spectral peak height of the unlabelled amino acid 
with that of the corresponding labelled amino acid and averaging the re-
sults from the five measurements. 
The EI mass spectra of amino acid derivatives were recorded on a 
Quadruple EAI 300 mass spectrometer. The source temperature was main-
tained at 200°C and the probe temperature was varied from ambient to 
200°C. The energy of the electron beam was 70 eV. In all cases, the 
sample was admitted through a direct insertion probe. The EI mass 
spectra of amino acid derivatives were recorded from 80 - 250°C and the 
characteristic amine fragment ion (M-COOCH3) of unlabelled and labelled 
(internal standard, if used) amino acids was used for ratio determination. 
For example, N-acety-phenylalanine-D^ and internal standard N-acetyl-
phenylalanine-D^ methyl esters were recorded at m/e 162 and 167, res-
pectively. 
G. Quantitative Calibration and Calculation 
Calibration curves of a single amino acid and of amino acid mixtures 
were determined by comparing the protonated molecular ion peak height 
(CI) or the amine fragment ion peak height (EI) of a concentration range 
of unlabelled amino acids with that of the appropriate isotopically 
labelled amino acids. This was done by a manual method in which five 
mass spectral scans were recorded on UV sensitive chart paper and the 
mean peak height ratios from these five measurements were calculated. 
Blood amino acid concentrations were calculated as follows: 
^ A ^ t ) - (Wt. of A A) calibration ^ ̂ QQ 
mg7o — — X :; ^ 
. A A \ 1 s a m p l e volume (—^^^—) calibration ^ 
A A* 
Where (A A / A A^) = mean peak height ratio of unlabelled to labelled 
amino acid, 
A A^ = labelled amino acid as internal standard, if amino 
acids are used, correction should be made for the natural 
abundance of 13c (1.08%) and D (0.016%) isotopes, and 
(f) = mean peak height ratio of unlabelled to labelled of internal 
standard. 
H. Mass Spectrometry of Stable Isotopically Labelled Amino Acids for 
Metabolic Studies 
The subject was fed orally 50 mg tyrosine-D2 or valine-Dy per kg body 
weight. Plasma sample (50 yl) taken at the time intervals indicated were 
deproteinized with 200 yl ethanol by centrifugation and derivatized with 
a mixture of acetic anhydride-methanol (10 yl + 50 yl) reagent at 100°C 
for 5 min. Aliquot of 10 yl was transferred into a probe tip sample 
holder, evaporated under vacuum and admitted through a direct insertion 
probe for direct CI mass spectrometry. The relative peak heights of the 
protonated molecular ions for unlabelled and labelled tyrosine (m/e 280 
for tyrosine-Do and m/e 282 for tyrosine-D2) and valine (m/e 174 for 
valine-DQ, m/e 180 for valine-D5 and m/e 181 for valine-Dy) were measured 
and averaged and the per cent deuterium content was calculated. Total 
concentration of the amino acids were determined by adding 12.5 n mole 
(5 yl of 2.5 iriM solution in 0.1 N HCl) of labelled tyrosine-D2 or valine-
D5 standard or of unlabelled (DQ) acid standard as required to the plasma 
samples and repeating the derivatization process and the mass spectral 
analysis. 
I. Analysis of Amino Acids in Urine, Saliva and Amniotic Fluids 
Amniotic fluid, saliva and urine samples (50 - 100 yl) were added to 
the reaction vials, and the appropriate labelled amino acid standards 
(12.5 n mole, 5 - 10 yl of 2.5 mM solution in 0.1 N HCl) were added. 
The solution was then evaporated to dryness under nitrogen at 80°C. The 
dry amino acid residue was redissolved in a mixture of acetic anhydride 
(10 - 20 yl) and methanol (50 - 100 yl) in the presence of molecular 
sieve 3A (1 stick) and then derivatized at 100°C for 5 min. and transferred 
to a sample holder, evaporated under vacuum prior to mass spectrometric 
determination. The relative peak height ratio of the protonated molec-
ular ions of unlabelled to labelled amino acids, for example, glycine 
(m/e 132 vs. 134), alanine (m/e 146 vs. 149), valine (m/e 174/180), etc. 
were determined and calculations for each amino acid concentration were 
were followed. 
J, Preparation of Peptide or Protein Acid Hydrolysates for Amino Acid 
Analysis by Mass Spectrometry and Ion-exchange Chromatography 
Peptide sample (5 mg) of Asp-Phe, Gly-Met-Phe, Asp-Gly-Met-Phe and 
Met-Asp-Val-Glu-Leu-Phe were weighed into a reaction tube and 2 ml of 
6 N HCl were added. After flushing with nitrogen, the tube was capped 
and the contents were heated for 22 h at 110°C. After removal of the 
solvent in vacuo, the residue was redissolved in distilled water (2 ml) 
and an aliquot (1 ml) of the hydrolysates was used for ion-exchange 
chromatography. For mass spectrometric analysis, the appropriate D or 
l^N labelled amino acid standards of 12.5 n mole (5 Pi of 2.5 mM solu-
tion in 0.1 N HCl) were added into the hydrolysate (2 - 8 yg) in duplicate 
and the mixture was then dried under nitrogen at 80°C. The dry amino 
acid residue was redissolved in a mixture of acetic anhydride-methanol 
(10 + 50 yl) reagent in the presence of molecular sieve 3A (1 stick) and 
the solution was heated at 100°C for 5 min. Aliquot of 10 yl of the 
solution was then transferred to a sample holder, evaporated to dryness 
under reduced pressure, and admitted through a direct insertion probe 
for MS analysis. The probe tip was then heated slowly in the ion source 
region of the mass spectrometer until the amino acid spectrum appeared on 
the oscilloscope display. The mass spectrum of N-acetyl amino acid 
methyl esters was recorded at 80 - 180°C with a background spectrum being 
recorded at 50°C. The peak height of the unlabelled and the labelled 
amino acid were measured and the peak height ratio for each amino acid 
was calculated, for example, aspartic acid (m/e 204 vs. 205), glutamic 
acid (m/e 218 vs. 219), leucine (m/e 188 vs. 189) and methione 
(m/e 206/209), etc. The amino acid residue of each peptide was calculated 
in terms of weight basis or mole basis using the formula described in 
Procedure G. 
For ion-exchange chromatography, the aliquot (30-70 yg) was dried 
with rotary evaporator and taken up in 2 ml of pH 2.2 c i t r a t e buffer and 
analyzed on Beckman Model 120 B amino acid analyzer. 
K . Comparative Analysis of Plasma and Blood Phenylalanine using Mass 
Spectrometry, Ion-exchange Chromatography and Gas Chromatography 
For mass spectrometric analysis of blood phenylalanine, whole blood 
(5 \ll) was spotted on filter paper (Guthrie test paper) and dried at 
100°C for 10 min. The whole blood spot was then punched out using a 4 mm 
stainless cork puncher and placed in the reaction vial. The amino acids 
were extracted with 200 yl alcohol (80%) containing the appropriate 
amount of Phe-D3 (12.5 n mole, 5 yl of 2.5 mM solution in 0.1 N HCl) by 
sonication for 5 min. and derivatized with a mixture of acetic anhydride-
methanol (10 + 50 yl) at 100°C for 5 min. and analyzed by direct CI mass 
spectrometry (mass number m/e 222 vs. m/e 227) and EI-MS (m/e 162 vs. 
m/e 167). Plasma (50 yl) of the same blood sample was deproteinized 
with alcohol (200 yl) containing the internal standard Phe-D5 (25 n mole, 
10 yl of 2.5 mM in 0.1 N HCl) and the supernatant was treated according 
to Procedure B. Plasma (100 yl) of the same blood specimens was de-
proteinized with 37o sulfosalicylic acid and was analyzed for free amino 
acid levels by ion-exchange chromatography based on a standard method of 
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Beckman Model 120 B Amino Acid Analyzer. For gas chromatography, plasma 
(50 yl) was deproteinized first with alcohol (200 lil) and the supernatant 
containing the internal standard (a-amino caprylic acid, 25 n mole, 10 \il 
of 2.5 mM in 0.1 N HCl) was dried with nitrogen and the residue was deriv-
atizedC^^jS^). The derivatization procedure involves a direct esterifi-
cation and acylation. For this purpose, the dry residue was first 
sonicated with HCl/n-butanol (3 N, 150 Ul) and heated for 15 min. at 
100°C. The solution was then evaporated to dryness with nitrogen at 
80°C. For acylation, a solution of trifluoroacetic anhydride-dichloro-
methane (1: v/v, 100 PI) was then added, sonicated and heated for 5 min. 
at 150°C. Aliquot of 5 yl solution was injected into an EGA column 
(0.325% on 80/100 mesh a.w. HT Chromosorb G, 6 in x 1/2 in I.D., U-glass) 
of a Tractor MT 220 gas chromatograph equipped with a Coulson nitrogen 
detector. Initial temperature, 80°C, program 5°/min. Helium flow 
(carrier) was maintained at 60 ml/min., and the detector pyrolyzer at 
10 ml/min. Hydrogen flow in the pyrolyzer was 50 ml/min., and the 
pyrolyzer temperature was 820°C. 
L. Comparative Analysis of Blood Spot Using Mass Spectrometry and 
Guthrie Test 
Blood spot samples were first screened by Guthrie bacterial inhibi-
tion and the phenylketonuric (PKU) positive samples were 
subjected to mass spectrometric analysis. The MS analysis included two 
experiments: (1) the calibration of known blood spots (Guthrie Test 
standard, 5 yl) containing 2 - 20 mg% phenylalanine as reference; and 
(2) the analysis of Guthrie Test blood spots (10-15 mm). In the first 
experiments, each 5 yl blood spot run in duplicate was extracted with 
ethanol (200 yl, 80%), and the extract was dried with nitrogen. 
redissolved in a mixture of acetic anhydride-methanol (10 + 50 yl) and 
derivatized in the presence of 12.5 n mole of Phe-D^ (5 yl of 2.5 raM in 
0.1 N HCl)at 100°C for 5 min. followed by MS analysis. The results of 
these experiments showed a straight line relationship between the blood 
phenylalanine level and the spectral data of peak height ratio (m/e 222 
for Phe vs. m/e 227 for Phe-D5). In the second experiments, the large 
blood spots (10-15 mm) on Guthrie Test paper were punched out 4 mm discs 
(5.5 yl blood volume) from the center or off the center. The discs, run 
in duplicate, were sonicated with 80% ethanol (200 yl) containing 12.5 n 
mole (5 yl of 2.5 mM in 0.1 N HCl) Phe-D5. The amino acid extracts were 
then dried under nitrogen at 80®C and derivatized with a mixture of 
acetic anhydride-methanol (10 + 50 yl) in the presence of molecular sieve 
3A (1 stick) at 100°C for 5 min. Aliquots of 10 yl were then transferred 
to a sample holder, evaporated to dryness under vacuum, and admitted 
through a direct insertion probe for MS analysis. The mass spectrum of 
N-acetylphenylalanine methyl ester was then recorded at 80 - 180°C with 
a background spectrum being recorded at 50°C. The peak height of the un-
labelled and the labelled phenylalanine derivative (m/e 222 and m/e 227) 
were measured and the peak height ratio, m/e 222 vs. 227, and phenyl-
alanine concentration were calculated. 
A number of 'old' filter paper samples were also analyzed by MS and 
the analytical results were compared with Guthrie Test for phenylalanine 
screening program dated 1975. 
II. Quantitative Analysis of Fatty Acids 
Laurie acid (Ci2:o). myristic acid (C14.0), palmitic acid (CI^.Q) 
and stearic acid (Ci8:0) ^^^^ obtained from Sigma Chemical Co., 
(St. Louis, USA), phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) 
and BF3-methanol reagent (14% w/v) from Applied Science Lab., Inc. (State 
College, USA); acetic anhydride-D^ and D2SO4 from Merck Sharp and Dohme 
(Montreal, Canada) and deuterium oxide from the Atomic Energy Commission 
(Lucas Heights, Australia). 
A, Gas Chromatography of Fatty Acids 
The fatty acid composition (w/w7o) of a standard fatty acid mixture 
(Cl2:0> ^14-0, Ci6:0> Ci8:0 1:1:2:1.5 w/w) was determined by gas chroma-
tography of their methyl ester derivatives using BF3-methanol reagent. 
The mixture in chloroform was evaporated to dryness with nitrogen and 
BF3-methanol reagent (50 yl) was added to the dry residue and heated at 
100°C for 5 min. Aliquots of the solution (3 yl) were analyzed on a 
Varian Series 2700 G.C. using a 6 ft x 1/8 in. stainless steel Apiezon N 
column on 80/100 mesh chromosorb W (AW/DMCS treated). A helium flow of 
30 ml/min. and a 10°C/min. temperature program from 160°C was used. 
B. Preparation of a-Deuterated Fatty Acid Standards 
Deuterium labelled saturated fatty acids were prepared by a modifica-
tion of van Heyningen's technique(75). A standard solution of fatty acid 
(0.2 mg of Ci2:0 to Ci8:0 or phytanic acid) in chloroform (0.2 ml) was 
transferred to a screw top reaction vial (ca. 2 ml capacity) and the 
solvent was removed with nitrogen. Acetic anhydride-D^ (100 yl), D2O 
(100 yl) and conc. D2SO4 (25 yl) were then added. The vial was capped 
and then heated at 150 - 160°C for 20 h. The vial was then cooled and 
vented and the labelled fatty acids were extracted into hexane (400 yl), 
washed with H2O (400 yl) and dried. Deuterium incorporation was deter-
n.ined by mass spectroscopy. The fatty acid standards showed a minimum 
isotopie purity of 86% D in the two a-positions, e.g., Ci2:0 (93%), C14.0 
(91%), Ci6:0 (88%), Ci8:0 (86%) and phytanic acid (91%). 
C. Mass Spectrometry of Pure Fatty Acid 
The C I mass spectra were recorded on a Dupont 21-491 B mass 
spectrometer in the chemical ionization (CI) mode using isobutane at 0.5 -
1.0 Torr. The instrumental conditions used were the same as for amino 
acid analyses except that the mass spectra were recorded at 20°C intervals 
from 80 - 180°C. 
To a reaction vial was added a single fatty acid (Cj^2-0i ^14* 0> 
^16:0J ^18:0°^ phytanic acid 5 yg) dissolved in chloroform (10 yl) or a 
fatty acid mixture (5 Pg of each acid dissolved in 10 y l chloroform for 
each fatty acid component present) and a deuterated internal standard 
(CI2:0-D2, CI4:0-D2, CI6:0-D2, Ci8:0-D2 O^ phytanic acid-D2, 5 Pg/lO m l 
chloroform) and the solution was transferred to a sample holder, evapo-
rated to dryness under vacuum, and admitted through a direct insertion 
probe for MS analysis. The mass number of free fatty acid and their cor-
responding internal standard by CI-MS are summarized in Table 37. 
D . Free Fatty Acid Analysis in Dried Blood Spot 
To a reaction vial was added a chloroform-methanol mixture (400 yl, 
2:1 v/v), the appropriate deuterium labelled fatty acid standard (2 yg in 
10 y l chloroform), and the dry blood spot (4 mm filter paper disc, 5.5 y l 
blood). It was then ultrasonically mixed for 5 min. and the filter paper 
disc which retains the protein and other chloroform-methanol insoluble 
components was removed with tweezers. The solution was then evaporated 
to dryness with nitrogen at 80°C and the dry residue was redissolved in 
chloroform (25 yl). A n aliquot (10 yl) of the solution was transferred 
to a probe tip and most of the solvent was evaporated under vacuum and 
the dry residue analyzed by direct mass spectrometry for C]^2:0 ^20:0 
at m/e 201 to m/e 313. 
Table 37. Mass number of free fatty acid used for ratio 
determination by CI mass spectrometry 
Fatty Acid 
Mass Number (MH+,m/e) 
Unlabelled / Labelled 
Internal 
(D) 
Standard 
^12:0 201 / 203 ^12:0 -
^14:0 229 / 231 ^14:0 - »2 
257 / 259 ^16:0 -
•̂ 18:0 285 / 287 ^18:0 - D2 
<̂ 20:0 313 / 315 ^20:0 - »2 
(Phytanic acid) 
E. Quantitative Calibration and Calculation 
Calibration curves of fatty acid mixtures phytanic 
acid (C20:o) "were determined for a concentration range of 0 - 2.0 yg. 
To a reaction vial was added a chloroform-methanol mixture (400 yl, 
2:1 v/v), the appropriate deuterated internal standard (1.0 yg in 5 yl 
chloroform) and the free fatty acids (0 - 2.0 yg in chloroform, 1 yg/5 yl). 
It was then sonicated for 5 min. and the content was concentrated to 25 -
30 yl. An aliquot of 10 yl of the solution was transferred to a probe 
tip and the solvent was evaporated under vacuum and admitted to the mass 
spectrometer. The peak height ratios were determined by comparing the 
protonated molecular ion peak height of the unlabelled with the corres-
ponding labelled fatty acid, e.g., for C]̂ 2;0 ̂ ^ ^^^ ^^^ ^14;0 ^^ 
m/e 229/231, etc., and averaging the results from five measurements. 
A calibration curve for a blood fatty acid was determined using 
labelled stearic acid. This was done by adding a chloroform-methanol 
mixture (400 yl, 2:1 v/v), the appropriate deuterated stearic acid 
(CI8-0"^2) ^^ ^^ ̂ ^ chloroform), and the dry blood spot (20 yl, 
dried at 100°C/10 min.) to a reaction vial. The blood fatty acids were 
then extracted by sonication (5 min.) and the solution was concentrated 
after the removal of the paper disc. An aliquot (10 yl) of the solution 
(25-30 yl) was transferred to a probe tip and the solvent was evaporated 
under vacuum and admitted to the mass spectrometer. The peak height 
ratios were determined by comparing the peak height of the unlabelled 
stearic acid with the labelled stearic acid (m/e 285/287) and averaging 
the results from five measurements. 
Blood fatty acid concentrations were calculated using the same 
formula as described in the amino acid section G (see page 107). 
F. Analysis of Free Phytanic Acid in Blood 
(a) Dry Blood: To a reaction vial was added a chloroform-methanol 
mixture (400 yl, 2:1 v/v), 2.5 \ig phytanic acid-D2 (in 5 yl chloroform), 
and the dry blood spots (2 disc, 4 mm dia. containing 5.5 yl each). It 
was then sonicated for 5 min. and the filter paper discs were removed. 
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The solution was then concentrated to 25 - 30 yl with nitrogen at 80 C. 
An aliquot (10 yl) of the solution was transferred to a probe tip and was 
evaporated under vacuum and the dry residue analyzed by direct mass 
spectrometry. The peak height ratios were determined by comparing the 
peak height of the unlabelled to corresponding labelled phytanic acid 
(m/e 313/315) and averaging the results from five measurements. Blood 
phytanic acid concentrations were calculated as previously described for 
fatty acids. 
(b) Plasma and Serum: To a reaction vial was added 2.5 yg phytanic 
acid-D2 (in 5 yl chloroform) and the solvent was evaporated with nitrogen 
at 80°C followed by the addition of 100 yl acetone and 10 yl plasma or 
serum. The content was sonicated for 1 min. and evaporated to dryness 
with nitrogen at 80°C. The dry residue was redissolved in a chloroform-
methanol mixture (100 yl, 2:1 v/v) and sonicated again for 5 min. The 
solution was then concentrated to 25 - 30 Ul and an aliquot of 10 yl was 
transferred to a probe tip and the solvent was evaporated under vacuum 
and the dry residue analyzed by direct mass spectrometry for phytanic 
acid (m/e 313). 
III. Quantitative Analysis of Cholesterol 
Cholesterol was obtained from the British Drug Houses, Ltd. (Pool, 
England). Cholesteryl palmitate and cholesteryl stearate were supplied 
by Applied Science Lab., Inc. (State College, USA). 
A. Preparation of Deuterium Labelled Cholesterol Standard 
The deuterated cholesterol was prepared using a variation on the 
method of Diekman and Djerassi(76)^ Dauben and Eastman(87)j and Ringold 
and Malhotra(S8) , A4-cholesten-3-one (200 mg), +-butanol-OD (7 ml) and 
potassium +-butoxide (500 mg) were stirred under nitrogen for 3 hours. 
The mixture was cooled and acidified with a mixture of acetic acid -QD^ 
and D2O, extracted with CH2CI2 and the organic layer washed (water, 2x), 
dried (MgS04) and evaporated. T.l.c. showed a mixture of A4- and A5-
cholesten-3-ones (approx. 1:1) which were separated by prep, t.l.c. 
(Si02; ethyl acetate/60-80 pet. ether (1:4)). The zone corresponding to 
A4-cholesten-3-one (90 mg) isopropenyl acetate (1.0 ml), D2SO4 (10 yl) 
were refluxed for 20 min. Sodium acetate (50 mg) was added to the solu-
tion and the liquid removed under vacuum. The solid residue was washed 
with chloroform (3x, 5 ml) and the washings decanted and evaporated. The 
residue (90 mg) was taken up in methanol and the solution stirred at room 
temperature during the addition of NaBD^ (100 mg in 5 ml methanol). The 
solution was refluxed for 30 min., cooled and hydrochloric acid (3 ml, 
2N) added dropwise, and then distributed between ethyl acetate and 
water. The organic layer was washed with H2O (2x) dried and evaporated 
and the product crystallized from methanol (30 mg, m.p. 143-146). The 
CI mass spectral analysis showed a mixture of species D^ - D5 with D4 
predominating, e.g., Di (4%), D2 (12%), D3 (24%), D4 (32%) and D5 (28%). 
B. Preparation of Deuterium Labelled Cholestryl Stearate Standard 
The deuterated cholesterol esters, e.g., cholestryl stearate and 
cholesteryl palmitate, were prepared using the method of Fieser and 
Schneider(80). Recrystallized stearic acid (20 mg) in benzene (2 ml) and 
pyridine (1 drop) were cooled to 0° and treated with oxalyl chloride 
(200 Ul dropwise) . Gas was evolved and the solution allowed to warm to 
room temperature after which the solvent was removed under vacuum. Suc-
cessive portions of benzene (2 ml) were added and evaporated and the 
residue, in 2 ml warm toluene treated with the above deuterated choles-
terol (5 mg) in benzene with three drops pyridine present. Pyridine 
hydrochloride crystallized slowly and the solution left standing at room 
temperature overnight. The solution was diluted with ether and washed 
with water (2x), dilute Na2C03 solution (Ix), 1 N HCl (Ix) and water (2x), 
dried (MgS04) and evaporated. The residue was crystallized from acetone 
(m.p. 68-71°) and yield = 5 mg (lit. m.p. 78). The CI mass spectral anal-
ysis showed a mixture of species D^ - D5 with D4 predominating, e.g., Dx 
(4%), D2 (137o), D3 (23%), D4 (33%) and D5 (27%). 
C. Preparation of Deuterium Labelled Cholesteryl Palmitate Standard 
Cholesteryl palmitate was prepared in an identical manner using 
recrystallized palmitic acid (20 mg) dissolved in benzene (2 ml) and 
pyridine (1 drop). The solution was cooled to 0° and treated with oxalyl 
chloride (200 ul dropwise) . Gas was evolved and the solution allowed to 
warm to room temperature after which the solvent was removed under vacuum. 
Successive portions of benzene (2 ml) were added and evaporated and the 
residue, in 2 ml warm toluene treated with the above deuterated choles-
terol (5 mg) in benzene with three drops pyridine present. Pyridine 
hydrochloride crystallized slowly and the solution left standing at room 
temperature overnight. The solution was diluted with ether and washed 
with water (2x), dilute Na2C03 solution (Ix), 1 N HCl (Ix) and water (2x), 
dried (MgS04) and evaporated. The residue was crystallized from acetone 
(m.p. 69-71) and yield = 5 mg (lit. m.p. ?). The mass spectral analysis 
showed that the deuterium labelled cholesteryl palmitate contained a 
mixture of species D^ - D5 with D4 predominating, e.g., Di (4%), D2 (13%), 
D3 (23%), D4 (33%) and D5 (27%). 
D. Mass Spectrometric Analysis of Cholesterol (BDH) 
Cholesterol (0.5-2 ]ig in chloroform solutions 0.5-2 yl) were 
transferred to a micro-vial (0.5 ml capacity) and the appropriate 
deuterated cholesterol standard solutions (chloroform, 1 Ug/yl) was added. 
The mixture was then transferred to a probe tip sample holder, evaporated 
under vacuum, and admitted to the mass spectrometer using a heatable di-
rect insertion probe. The CI mass spectrometry of cholesterol was 
carried out in the same way as that for the amino acids and fatty acids 
except that the spectra of cholesterol were recorded from 100 - 150°C. 
The dehydrated peak (MH - H2O)"'" of cholesterol (m/e 369) and that of 
internal standard D4 (m/e 373) were monitored and the peak height ratio 
of unlabelled to labelled cholesterol was calculated. 
E. Mass Spectrometric Analysis of Blood Cholesterol 
(a) Free Cholesterol 
To a reaction vial was added chloroform-methanol (2:1 v/v, 200 yl), 
cholesterol-D4 standard (5 Pg in 5 yl chloroform solution) and a 5 yl 
blood spot (punched out with 4 mm diameter puncher from 5 yl whole blood 
spotted on Guthrie Test filter paper); and the mixture was sonicated 
for 5 min. The filter paper was then removed with tweezers and the 
solution was evaporated to dryness with a stream of nitrogen at 80°C. 
Hexane (25 yl) was then added to the dry residue and an aliquot of 10 yl 
solution was then transferred to a sample holder, evaporated to dryness 
under reduced pressure, and admitted through a direct insertion probe for 
MS analysis. The probe tip was then heated slowly in the ion source 
region of the mass spectrometer until the free cholesterol spectrum 
appeared on the oscilloscope display (80-180°C). The mass spectrum of 
free cholesterol was recorded at 140 - 160°C with a background spectrum 
being recorded at 50°C. The peak height of the unlabelled and the 
labelled cholesterol were measured and the peak height ratio for 
molecular ion (MH+) , e.g., m/e 487 vs. 391, and for dehydrated peak ion 
(MH-H2O), e.g., m/e 369 vs. 373 were monitored. The blood free choies-
terol levels were also determined by thin-layer chromatography according 
to the procedure of Dutta et al.(77), The purified extract gave the same 
ratio between m/e 369 and 373 as did the original extract. 
(b) Total Cholesterol (Free + Bound Cholesterol) 
To the remaining hexane solution in the reaction vial, a mixture of 
sodium methoxide-methanol (Na/methanol, 0.5 N, 50 ]il) was added and the 
vial was capped and the contents heated at 100°C for 15 min. After 
cooling the solvent was evaporated under nitrogen and the dry residue was 
redissolved in hexane (25 yl) or chloroform (25 yl) and an aliquot (10 yl) 
was transferred to a probe tip holder, evaporated to dryness under re-
duced pressure, and admitted through a direct insertion probe for MS 
analysis. The probe tip was then heated slowly in the ion source region 
of the mass spectrometer until the free cholesterol spectrum appeared on 
the oscilloscope display. The mass spectrum of free cholesterol (after 
hydrolysis) was recorded at 140 - 160°C with a background spectrum being 
recorded at 50°C. The peak height of the unlabelled and the labelled 
cholesterol were measured and the peak height ratio for molecular ion 
(MH+) at m/e 387 vs. 391, and for dehydrated peak ion (MH-H2O) at m/e 369 
vs. 373 were calculated. 
Free and total cholesterol were calculated as follows: 
Total cholesterol, mgX ( ) sample -(f) chol-D4 (chol. wt) 
(or free cholesterol) = — Y " ; ^ sample volume 
( ^ ° • ) calibration chol-D4 
Where (f) = (Unlabelled (m/e 369)) p^^^ ^^ight ratio of Chol-D 
^ labelled (m/e 373) 
(c) Esterified Cholesterol 
To a reaction vial were added chloroform-methanol (200 yl; 2:1 v/v), 
deuterated cholesteryl palmitate or stearate (5 yg in 5 yl chloroform) 
and the dry blood spot (filter paper disc, 4 mm dia. containing 5 yl). 
The vial was capped and the contents ultrasonically mixed for 5 min. 
The filter paper disc was then removed with tweezers and the solution 
concentrateci down to about 25 - 30 ]il with nitrogen at 80°C. An aliquot 
(10 Ul) was transferred to a probe tip sample holder, evaporated under 
vacuum and admitted to the mass spectrometer for esterified cholesterol 
determinations by solid probe temperature programmed mass spectrometry 
at 270 + 10°C. Esterified cholesterol was calculated according to the 
above formula with the exception that "chol-D̂ ^̂ " should be replaced by 
deuterated cholesterol esters; "cholesteryl palmitate" or "stearate". 
Values of esterified cholesterol could be also obtained by the differences 
between total (procedure E-b) and free cholesterol (procedure E-a). 
At 270 + 10°C probe temperature range, the corresponding protonated 
cholesterol ester fatty acid peaks were also recorded, e.g., Cie^o " 
^20-0 ^^^ " 313). The profile of the esterified cholesterol could 
be elucidated by the presence and abundance of the fatty acids in the 
mass spectrum. 
F, Mass Spectrometric Analysis of Serum Cholesterol 
To a reaction vial was added chloroform-methanol (2:1 v/v, 200 yl), 
serum (5-10 Ul) and cholesterol-D4 (5 Ug in 5 ]il chloroform); and the 
mixture was sonicated for 5 min. and then evaporated to dryness under 
nitrogen at 80°C. The dry residue was then redissolved in hexane (25 yl). 
An aliquot (10 yl) of the mixture was used for free cholesterol 
analysis. This was done by transferring 10 yl solution to a sample 
holder, evaporating to dryness under reduced pressure, and admitting the 
residue through a direct insertion probe for MS analysis. The probe tip 
was then heated slowly in the ion source region of the mass spectrometer 
until the free cholesterol spectrum appeared on the oscilloscope display 
(80-180^0. The mass spectrum of free cholesterol was recorded at 140 -
160°C with a background spectrum being recorded at 50°C. The peak height 
of the unlabelled and the labelled cholesterol were measured and the peak 
height ratio for molecular ion (MH+), e.g., m/e 387 vs. 391, and for 
dehydrated peak ion (MH-H20)'^, e.g., m/e 369 vs. 373 were monitored. The 
serum free cholesterol levels were calculated after calibration (proce-
dure E-c) . 
The remaining portion of hexane solution in the reaction vial was 
hydrolyzed with sodium/methanol solution (50 Ul, 0.5 N) at 100°C for 
15 min. and analyzed for Total Cholesterol. An aliquot (10 yl) was trans-
ferred to a probe tip holder, evaporated to dryness under reduced pres-
sure, and admitted through a direct insertion probe for MS analysis. The 
probe tip was heated slowly in the ion source region of the mass 
spectrometer until the free cholesterol spectrum appeared on the oscil-
loscope display. The mass spectrum of free cholesterol (after hydrolysis) 
was recorded at 140 - 160°C with a background spectrum being recorded at 
50°C. The peak height of the unlabelled and the labelled cholesterol 
were measured and the peak height ratio for molecular ion (MH+) at m/e 487 
vs. 391, and for dehydrated peak ion (MH-H20)'^ at m/e 369 vs. 373 were 
calculated. The serum samples were also analyzed for total cholesterol 
levels by a routine Liebermann-Burchard Procedure and by an enzymatic 
m e t h o d ^ 7 8 ) and later was conducted at the Wollongong Hospital, Wollongong, 
N.S.W., Australia. 
G. Hydrolysis of Cholesterol Esters 
Chemical hydrolysis was carried out to free the fatty acid (or 
protein) bound cholesterols in estimation of total cholesterol levels in 
blood or serum via the route of free cholesterol analysis. 
(a) Acid Hydrolysis with HCl-Methanol: To a reaction vial was 
added cholesteryl palmitate or cholesterol stearate (5 Ug in 5 yl 
chloroform) or blood spot (5 yl) extract (chloroform-methanol, 2:1 v/v, 
200 yl) and cholesterol-D^ internal standard (5 yg In 5 \il chloroform), 
and the solvent was evaporated with nitrogen at 80°C. The dry residue 
was redissolved in 5% HCl/methanol reagent (50-100 yl) and the solution 
was heated at 100 - 150°C for 5 - 3 0 min. An aliquot (10 yl) of the 
mixture was then used for free cholesterol analysis by mass spectrometry. 
The mass spectrum of free cholesterol (after hydrolysis) was recorded at 
140 - 160°C with a background spectrum being recorded at 50°C. The peak 
height of the unlabelled (m/e 369) and the labelled (m/e 373) cholesterol 
were measured and the peak height ratios for dehydrated peak ion (MH-H20)'^ 
at m/e 369 vs. 373 were calculated. The maximum recovery was determined 
which was based on the measurement of peak height ratio at m/e 369 vs. 
373. 
(b) Alkaline Hydrolysis with KOH - Ethanol: 
To a reaction vial was added cholesteryl palmitate or cholesteryl 
stearate (5 yg in 5 yl chloroform) or blood spot (5 yl) extract (chloro-
form-methanol, 2:1 v/v, 200 yl) and cholesterol-D4 internal standard (5 yg 
in 5 yl chloroform) , and the solvent was evaporated with nitrogen at 
80°C. The residue was redissolved in KOH - ethanol reagent (0.5 and 1.0 
N, 50-100 yl) and the solution was heated at 100 - 150°C for 5 - 3 0 min. 
An aliquot (10 yl) of the mixture was then used for free cholesterol 
analysis by M.S. at solid probe temperature 150 + 10°C with a background 
spectrum being recorded at 50°C. The peak height of the unlabelled 
(m/e 369) and the labelled (m/e 373) cholesterol were monitored and 
measured and the peak height ratios for dehydrated peak ion (MH-H20)+ 
at m/e 369 vs. 373 were calculated. The maximum recovery was determined 
which was based on the measurement of peak height ratio at m/e 369 vs. 
373. 
(c) Alkaline Hydrolysis with Na - Methanol 
To a reaction vial was added cholesteryl palmitate or cholesteryl 
stearate (5 yg in 5 ul chloroform) or blood spot (5 yl) extract (chloro-
form-methanol, 2:1 v/v, 200 Ul) and cholesterol-D^^ (5 Pg in 5 yl chloro-
form), and the solvent was evaporated with nitrogen at 80°C. The residue 
was redissolved in 50 - 100 yl sodium methoxide reagent (Na/methanol, 
0.5 N) and heated at 100 - 150°C for 5 - 3 0 min. An aliquot of 10 yl 
solution was used for free cholesterol analysis by M.S. at solid probe 
temperature 150 + 10 C with a background spectrum being recorded at 50°C. 
The peak height of the unlabelled (m/e 369) and the labelled (m/e 373) 
cholesterol were monitored and the peak height ratios for dehydrated peak 
ion (MH-H2O) at m/e 369 vs. 373 were calculated. The maximum recovery 
was determined which was based on the measurement of peak height ratio 
at m/e 369 vs. 373. 
The best condition (near 100% recovery) to release bound cholesterol 
from its lipoprotein complex and its esters was found to be the method of 
heating cholesterol ester samples with Na/MeOH solution (0.5 N) at 100°C 
for 15 min. 
H. Quantitation Calibration and Calculation 
(a) Pure Cholesterol 
To each reaction vial was added 20 yl chloroform, a fixed amount of 
cholesterol-D^ (1.0 yg in 1.0 yl chloroform) and varying amounts of a 
reference cholesterol solution (0-2.0 yg, 1 yg/yl chloroform). After 
mixing, an aliquot of 10 yl solution was then transferred to a sample 
holder, evaporated to dryness under reduced pressure, and admitted 
through a direct insertion probe for MS analysis. The probe tip was 
heated slowly to 140 - 160°C in the ion source region of the mass 
spectrometer until the maximum peak intensity of the free cholesterol 
appeared on the oscilloscope display. Calibration curves of the pure 
cholesterol was determined by (1) comparing the dehydrated peak (MH-H20)'^ 
height at m/e 369 of the unlabelled cholesterol to that of the correspond-
ing labelled standard at m/e 373; and (2) comparing the sum of (M)"̂  and 
(M-H)"^ peak height (m/e 386 + 385) of the unlabelled cholesterol to that 
of the corresponding labelled standard (m/e 390 + 389). This was done 
by a manual method in which five mass spectral scans were recorded on UV 
sensitive chart paper and the mean peak height ratios were compiled. 
(b) Blood Cholesterol 
To each reaction vial was added 5 yl blood (4 mm discs containing 
0-10.0 yg added cholesterol), a fixed amount of choiesterol-D^ (5 yg in 
5 yl chloroform) and a mixture of chloroform-methanol (2:1 v/v, 200 yl). 
The solution was sonicated for 5 min. and an aliquot of 10 yl was trans-
ferred to a sample holder, evaporated to dryness under reduced pressure, 
and admitted through a direct insertion probe for MS analysis. The 
probe tip was heated slowly to 140-160°C in the ion source region of the 
mass spectrometer until the maximum peak intensity of the free choles-
terol appeared on the oscilloscope display. Calibration curves of the 
blood cholesterol was determined by comparing the dehydrated peak (MH-
H20)+ height at m/e 369 of the unlabelled cholesterol to that of the 
corresponding labelled standard at m/e 373. This was done by a manual 
method in which 5 mass spectral scans were recorded on UV sensitive 
chart paper and the mean peak height ratios were compiled. 
(c) Blood Cholesterol Ester 
To each reaction vial was added 5 yl blood (4 mm discs containing 
0-9.0 yg added cholesterol palmitate), a fixed amount of cholesterol 
palmitate-D^ (5 yg/5 yl chloroform) and a mixture of chloroform-methanol 
(2:1 v/v, 200 yl). The solution was sonicated for 5 min. and an aliquot 
of 10 yl was transferred to a sample holder, evaporated to dryness under 
reduced pressure, and admitted through a direct insertion probe for MS 
analysis. The probe tip was heated slowly to 260 - 280°C in the ion 
source region of the mass spectrometer until the maximum peak intensity 
of the dehydrated cholesterol peak (m/e 369) appeared on the oscilloscope 
display. Calibration curves of the blood cholesterol ester was deter-
mined by comparing the dehydrated peak (MH-H20)"^ height at m/e 369 of the 
unlabelled cholesterol ester to that of the corresponding labelled 
standard at m/e 373. This was done by a manual method in which 5 mass 
spectral scans were recorded on UV sensitive chart paper and the mean 
peak height ratios were compiled. 
IV. Quantitative Analysis of Estrogens 
Estrogen, e.g., estrone, estradiol and estriol, were obtained from 
ICN Biochemicals (Irvine, USA). 
A. Preparation of Deuterium Labelled Estrogens Standard 
The deuterated estrogens were prepared using a method of Fried and 
Edwards^^^). Estrone, estradiol or estriol (20 mg) in methanol-OD (5 ml) 
with D2SO4 (1 drop in 0.5 ml D2O) was refluxed for 5 days. After cooling, 
the reaction mixture was diluted with ether, washed with dilute NaHC03 
(2x) and water (2x), dried (MgS04) and evaporated. The product was re-
crystallized (ether-hexane) m.p. 172 - 174 . The mass spectral (CI) 
analysis of the labelled estrogens showed a mixture of species D^, Dĵ  and 
D2 with D2 predominating (50% D2). 
B. Analysis of Pure Estrogens 
The CI mass spectra of estrone (m/e 271), estradiol (m/e 273) and 
estriol (m/e 289) were recorded at solid probe temperatures of 100 -
200°C. The dehydrated peak (MH-H20)'^ of the corresponding estrogens 
(m/e 253 for estrone, m/e 255 for estradiol and m/e 271 for estriol) and 
their ion intensity in term of peak height were calculated. A calibra-
tion curve (peak height ratio vs. concentration) for estriol (m/e 289) 
with internal standard estriol-D2 (m/e 291) was determined by using a 
fixed amount of estriol-D2 (4 Ug, 1 yg/5 yl ethanol) and a concentration 
range of estriol (0-8 Ug, 1 yg/5 yl ethanol). 
C. Analysis of Urinary Estriol 
Urine (100 yl) was transferred to screw cap reaction vial and HCl 
(200 yl, 2N) was added. The contents were mixed and the tube was heated 
at 120°C for 15 min. After hydrolysis, the tube was cooled and the 
deuterated estriol (D2) standard (2 yg, in 10 yl ethanol) was added. 
The sterols were then extracted with diethyl ether (600 yl) using a 
Vortex mixing for 2 min. followed by separation of the layers. The 
diethyl ether layer was then transferred into a small vial and evaporated 
to dryness under nitrogen at 80°C. The dry residue was redissolved in 
ethanol (25 yl), and an aliquot of 10 yl was used for mass spectro-
metric analysis. The m/e values of unlabelled estriol and labelled 
estriol-D2 at 289 and 291 and their peak height ratio (m/e 289 vs. 
m/e 291) were monitored. The value of estriol levels in urine samples 
was obtained using a similar formula described for amino and fatty acids 
analyses. Urine samples were also analyzed for estrogens by Technicon 
Automated Estrogen Assay with fluroimetric and point m e t h o d ( 8 2 ) and the 
assay was conducted at Royal Prince Alfred Hospital Endocrine Laboratory, 
Camperdon, Sydney. 
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